<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva, formerly WebFilings-->
<!-- -->
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <roleRef roleURI="http://www.cancergenetics.com/role/CapitalStock" xlink:href="cgix-20140630.xsd#CapitalStock" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/CapitalStockAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#CapitalStockAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cgix-20140630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:href="cgix-20140630.xsd#ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="cgix-20140630.xsd#ConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/ConsolidatedStatementsOfOperationsUnaudited" xlink:href="cgix-20140630.xsd#ConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/Contingencies" xlink:href="cgix-20140630.xsd#Contingencies" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/DescriptionOfBusinessBasisOfPresentationAcquisitionPendingAcquisitionPublicOfferingsAndReverseStockSplits" xlink:href="cgix-20140630.xsd#DescriptionOfBusinessBasisOfPresentationAcquisitionPendingAcquisitionPublicOfferingsAndReverseStockSplits" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/DescriptionOfBusinessBasisOfPresentationPendingAcquisitionPublicOfferingsAndReverseStockSplitsAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#DescriptionOfBusinessBasisOfPresentationPendingAcquisitionPublicOfferingsAndReverseStockSplitsAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/DocumentAndEntityInformation" xlink:href="cgix-20140630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueMeasurements" xlink:href="cgix-20140630.xsd#FairValueMeasurements" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueMeasurementsSummaryOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="cgix-20140630.xsd#FairValueMeasurementsSummaryOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueMeasurementsTables" xlink:href="cgix-20140630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrants" xlink:href="cgix-20140630.xsd#FairValueOfWarrants" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrantsAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#FairValueOfWarrantsAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrantsAssumptionsUsedInComputingFairValueOfDerivativeWarrantsDetail" xlink:href="cgix-20140630.xsd#FairValueOfWarrantsAssumptionsUsedInComputingFairValueOfDerivativeWarrantsDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrantsSummaryOfDerivativeWarrantActivityDetail" xlink:href="cgix-20140630.xsd#FairValueOfWarrantsSummaryOfDerivativeWarrantActivityDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrantsTables" xlink:href="cgix-20140630.xsd#FairValueOfWarrantsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/JointVentureAgreement" xlink:href="cgix-20140630.xsd#JointVentureAgreement" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/JointVentureAgreementAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#JointVentureAgreementAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/LetterOfCredit" xlink:href="cgix-20140630.xsd#LetterOfCredit" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/LetterOfCreditAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#LetterOfCreditAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/NotesPayableAndLineOfCredit" xlink:href="cgix-20140630.xsd#NotesPayableAndLineOfCredit" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#NotesPayableAndLineOfCreditAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditSummaryOfShortTermAndLongTermDebtObligationsDetail" xlink:href="cgix-20140630.xsd#NotesPayableAndLineOfCreditSummaryOfShortTermAndLongTermDebtObligationsDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditTables" xlink:href="cgix-20140630.xsd#NotesPayableAndLineOfCreditTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RelatedPartyTransactions" xlink:href="cgix-20140630.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RelatedPartyTransactionsAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#RelatedPartyTransactionsAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivable" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivable" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivableAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableScheduleOfAccountsReceivableByPayorTypeDetail" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivableScheduleOfAccountsReceivableByPayorTypeDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableScheduleOfRevenueByPayorTypeDetail" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivableScheduleOfRevenueByPayorTypeDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableTables" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivableTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPolicies" xlink:href="cgix-20140630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesComputationOfBasicNetIncomeLossAndDilutedNetLossPerShareDataDetail" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesComputationOfBasicNetIncomeLossAndDilutedNetLossPerShareDataDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesPolicies" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesSummaryOfPotentiallyDilutiveAdjustmentsToWeightedAverageNumberOfCommonSharesExcludedFromCalculationDetail" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesSummaryOfPotentiallyDilutiveAdjustmentsToWeightedAverageNumberOfCommonSharesExcludedFromCalculationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesTables" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlans" xlink:href="cgix-20140630.xsd#StockOptionPlans" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansEffectsOfStockBasedCompensationRelatedToStockOptionAwardsDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansEffectsOfStockBasedCompensationRelatedToStockOptionAwardsDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansSummaryOfEmployeeAndNonemployeeStockOptionActivityDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansSummaryOfEmployeeAndNonemployeeStockOptionActivityDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansSummaryOfOutstandingAndVestedStockOptionsGrantedDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansSummaryOfOutstandingAndVestedStockOptionsGrantedDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansTables" xlink:href="cgix-20140630.xsd#StockOptionPlansTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansWeightedAverageAssumptionsUsedToEstimateFairValueOfOptionsGrantedDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansWeightedAverageAssumptionsUsedToEstimateFairValueOfOptionsGrantedDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/Warrants" xlink:href="cgix-20140630.xsd#Warrants" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/WarrantsAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#WarrantsAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/WarrantsSummaryOfWarrantActivityDetail" xlink:href="cgix-20140630.xsd#WarrantsSummaryOfWarrantActivityDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/WarrantsTables" xlink:href="cgix-20140630.xsd#WarrantsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <presentationLink xlink:role="http://www.cancergenetics.com/role/CapitalStock" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_320CB32A19E08CFFEDD2CE191D6645EC" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_900E14DEC79F489538C6CE191D6779FC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_320CB32A19E08CFFEDD2CE191D6645EC" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_900E14DEC79F489538C6CE191D6779FC" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/CapitalStockAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_A0530B46CEC6951F6A50CAA0E4C99F26" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_C433A57B9D8C94236377CAA0E4C99F19" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_A0530B46CEC6951F6A50CAA0E4C99F26" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_C433A57B9D8C94236377CAA0E4C99F19" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_37B5EBE0B73DBA73ACE5CAA0E4C9095E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_C433A57B9D8C94236377CAA0E4C99F19" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_37B5EBE0B73DBA73ACE5CAA0E4C9095E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96D7769F2A5BD08AA427CAA0E4C98E98" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_37B5EBE0B73DBA73ACE5CAA0E4C9095E" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96D7769F2A5BD08AA427CAA0E4C98E98" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_SecondaryOfferingMember" xlink:label="loc_cgix_SecondaryOfferingMember_EC3560AFAB11B5C06CDCCAA0E4C9DB24" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96D7769F2A5BD08AA427CAA0E4C98E98" xlink:to="loc_cgix_SecondaryOfferingMember_EC3560AFAB11B5C06CDCCAA0E4C9DB24" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FollowOnOfferingMember" xlink:label="loc_cgix_FollowOnOfferingMember_58AA7D9EC010F7A54013CAA0E4CADD07" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96D7769F2A5BD08AA427CAA0E4C98E98" xlink:to="loc_cgix_FollowOnOfferingMember_58AA7D9EC010F7A54013CAA0E4CADD07" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_B625B7096F4025752C5BCAA0E4CABAA3" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_C433A57B9D8C94236377CAA0E4C99F19" xlink:to="loc_us-gaap_StatementClassOfStockAxis_B625B7096F4025752C5BCAA0E4CABAA3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_927372173DCFD25B6760CAA0E4CAFDC6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_B625B7096F4025752C5BCAA0E4CABAA3" xlink:to="loc_us-gaap_ClassOfStockDomain_927372173DCFD25B6760CAA0E4CAFDC6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_6E5E09B2FB2156E42868CAA0E4CA586A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_927372173DCFD25B6760CAA0E4CAFDC6" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_6E5E09B2FB2156E42868CAA0E4CA586A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5E9DDF28E7B12272BDD2CAA0E4CAC4B1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_927372173DCFD25B6760CAA0E4CAFDC6" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5E9DDF28E7B12272BDD2CAA0E4CAC4B1" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FacilityLocationAxis" xlink:label="loc_cgix_FacilityLocationAxis_7CB60A52394F1F228476CAA0E4CAC7B5" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_C433A57B9D8C94236377CAA0E4C99F19" xlink:to="loc_cgix_FacilityLocationAxis_7CB60A52394F1F228476CAA0E4CAC7B5" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FacilityLocationDomain" xlink:label="loc_cgix_FacilityLocationDomain_CA71EFC90EB51B74C07ACAA0E4CA6691" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_FacilityLocationAxis_7CB60A52394F1F228476CAA0E4CAC7B5" xlink:to="loc_cgix_FacilityLocationDomain_CA71EFC90EB51B74C07ACAA0E4CA6691" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ClevelandClinicMember" xlink:label="loc_cgix_ClevelandClinicMember_ECA759D3482090B9E25BCAA0E4CA0D39" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_FacilityLocationDomain_CA71EFC90EB51B74C07ACAA0E4CA6691" xlink:to="loc_cgix_ClevelandClinicMember_ECA759D3482090B9E25BCAA0E4CA0D39" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_C433A57B9D8C94236377CAA0E4C99F19" xlink:to="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_22D7618F54059502007DCAA0E4CAC275" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_us-gaap_CommonStockSharesIssued_22D7618F54059502007DCAA0E4CAC275" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_OverAllotmentOfShares" xlink:label="loc_cgix_OverAllotmentOfShares_41D633C5EE9A405C8C77CAA0E4CA3B4B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_cgix_OverAllotmentOfShares_41D633C5EE9A405C8C77CAA0E4CA3B4B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_CA0BB2A137AEEF88DAA3CAA0E4CAF27C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_CA0BB2A137AEEF88DAA3CAA0E4CAF27C" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_GrossProceedsFromOffering" xlink:label="loc_cgix_GrossProceedsFromOffering_B2AAAAC22BBD23FD299ACAA0E4CAB7CE" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_cgix_GrossProceedsFromOffering_B2AAAAC22BBD23FD299ACAA0E4CAB7CE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_93C7B320D7958268BE98CAA0E4CA03A1" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_93C7B320D7958268BE98CAA0E4CA03A1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_237DCF24B431B948764ACAA0E4CA6251" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_237DCF24B431B948764ACAA0E4CA6251" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CFBA21951973935055B7CAA0E4CA510E" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CFBA21951973935055B7CAA0E4CA510E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_38D6F877F9998FCE804DCAA0E4CAC786" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_38D6F877F9998FCE804DCAA0E4CAC786" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DerivativeLiabilityReclassifiedToStockholdersEquity" xlink:label="loc_cgix_DerivativeLiabilityReclassifiedToStockholdersEquity_7C48CD25530D5258B143CAA0E4CA82F5" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_cgix_DerivativeLiabilityReclassifiedToStockholdersEquity_7C48CD25530D5258B143CAA0E4CA82F5" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NetProceedsFromOffering" xlink:label="loc_cgix_NetProceedsFromOffering_7BF531FA165FD1140CE3CAA0E4CBE198" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_cgix_NetProceedsFromOffering_7BF531FA165FD1140CE3CAA0E4CBE198" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ProceedsFromOfferingUsedToRepayOutstandingIndebtedness" xlink:label="loc_cgix_ProceedsFromOfferingUsedToRepayOutstandingIndebtedness_23DFA2A229A9F7DFDB7CCAA0E4CBC52D" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_cgix_ProceedsFromOfferingUsedToRepayOutstandingIndebtedness_23DFA2A229A9F7DFDB7CCAA0E4CBC52D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ExcessStockSharesIssued" xlink:label="loc_us-gaap_ExcessStockSharesIssued_32A620C4F40B4D12DE54CAA0E4CBF2F8" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_us-gaap_ExcessStockSharesIssued_32A620C4F40B4D12DE54CAA0E4CBF2F8" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ProceedsFromIssuanceOfAdditionalCommonSharesGross" xlink:label="loc_cgix_ProceedsFromIssuanceOfAdditionalCommonSharesGross_174399D31D110A44F5EDCAA0E4CBF5B0" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_cgix_ProceedsFromIssuanceOfAdditionalCommonSharesGross_174399D31D110A44F5EDCAA0E4CBF5B0" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ProceedsFromIssuanceOfAdditionalCommonSharesNet" xlink:label="loc_cgix_ProceedsFromIssuanceOfAdditionalCommonSharesNet_02F5D682C70420CDAD88CAA0E4CB452D" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_cgix_ProceedsFromIssuanceOfAdditionalCommonSharesNet_02F5D682C70420CDAD88CAA0E4CB452D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_A6334D38CDACA2ADBE72CAA0E4CB7F9C" xlink:type="locator" />
    <presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_969EABE6E42137CE1222CAA0E4CAC48D" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_A6334D38CDACA2ADBE72CAA0E4CB7F9C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_BD508E3ED90B492BD50DCFE7EB386190" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_BD508E3ED90B492BD50DCFE7EB386190" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts" xlink:label="loc_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts_5E41083406A8DDE22EB4CFE7EB38A180" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:to="loc_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts_5E41083406A8DDE22EB4CFE7EB38A180" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_F1555F3AA3B680E50FC2CFE7EB38C929" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_F1555F3AA3B680E50FC2CFE7EB38C929" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4A44A6862E41B642FFB4CFE7EB38667B" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4A44A6862E41B642FFB4CFE7EB38667B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6902A68799D344914E90CFE7EB96FD87" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6902A68799D344914E90CFE7EB96FD87" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_BDCA3E5649EFA6E4283FCFE7EB3806ED" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_BDCA3E5649EFA6E4283FCFE7EB3806ED" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_12A22C21C67026B5122ACFE7EB38B327" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_12A22C21C67026B5122ACFE7EB38B327" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_275D50D05656999A9540CFE7EB389C3C" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:to="loc_us-gaap_CommonStockSharesIssued_275D50D05656999A9540CFE7EB389C3C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_08965B0199726AD8311BCFE7EB387E5D" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79ECBD6B220E5F80691ECFE7EB38BA72" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_08965B0199726AD8311BCFE7EB387E5D" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_46522F8F19A16D546E5ED11B22B22830" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_2F1F1F0E8986A27DDB32D11B22B20CFA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_46522F8F19A16D546E5ED11B22B22830" xlink:to="loc_us-gaap_AssetsAbstract_2F1F1F0E8986A27DDB32D11B22B20CFA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_A9DE09B0429B4FC6B786D11B22B24EA2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2F1F1F0E8986A27DDB32D11B22B20CFA" xlink:to="loc_us-gaap_AssetsCurrentAbstract_A9DE09B0429B4FC6B786D11B22B24EA2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_B131E66BE3339F986948D11B22B2DD73" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A9DE09B0429B4FC6B786D11B22B24EA2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_B131E66BE3339F986948D11B22B2DD73" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_A60562599B336D79DF3CD11B22B227B1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A9DE09B0429B4FC6B786D11B22B24EA2" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_A60562599B336D79DF3CD11B22B227B1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_214FD97173B9C89BEF30D11B22B2E76E" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A9DE09B0429B4FC6B786D11B22B24EA2" xlink:to="loc_us-gaap_OtherAssetsCurrent_214FD97173B9C89BEF30D11B22B2E76E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_DC75CCC71F720909DC00D11B22B254D7" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_A9DE09B0429B4FC6B786D11B22B24EA2" xlink:to="loc_us-gaap_AssetsCurrent_DC75CCC71F720909DC00D11B22B254D7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9B363BC22CD84479E340D11B22B365F7" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2F1F1F0E8986A27DDB32D11B22B20CFA" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9B363BC22CD84479E340D11B22B365F7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaap_OtherAssetsAbstract_DD79A8A67A4D8D951DDCD11B22B38CEB" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2F1F1F0E8986A27DDB32D11B22B20CFA" xlink:to="loc_us-gaap_OtherAssetsAbstract_DD79A8A67A4D8D951DDCD11B22B38CEB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_8CC0A07F5BC952D8D661D11B22B3B98B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_DD79A8A67A4D8D951DDCD11B22B38CEB" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_8CC0A07F5BC952D8D661D11B22B3B98B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_BCEA98144C044AB8F202D11B22B3FB90" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_DD79A8A67A4D8D951DDCD11B22B38CEB" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_BCEA98144C044AB8F202D11B22B3FB90" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesAndLoansReceivableGrossNoncurrent" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_76195E90701FCE90D03DD11B22B33CA2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_DD79A8A67A4D8D951DDCD11B22B38CEB" xlink:to="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_76195E90701FCE90D03DD11B22B33CA2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0AB240BB95713AEF2487D11B22B3A3AD" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_DD79A8A67A4D8D951DDCD11B22B38CEB" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0AB240BB95713AEF2487D11B22B3A3AD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1FAAEB04A48820FBE9CDD11B22B3A8BC" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_DD79A8A67A4D8D951DDCD11B22B38CEB" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1FAAEB04A48820FBE9CDD11B22B3A8BC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_FA21776CC8049CD0EA23D11B22B36BA1" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_DD79A8A67A4D8D951DDCD11B22B38CEB" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_FA21776CC8049CD0EA23D11B22B36BA1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_6BE0FCAB79CA70D01BF8D11B22B3729A" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2F1F1F0E8986A27DDB32D11B22B20CFA" xlink:to="loc_us-gaap_Assets_6BE0FCAB79CA70D01BF8D11B22B3729A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_46522F8F19A16D546E5ED11B22B22830" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_C7DCF8AE595AB5E0CF8BD11B22B392C9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_C7DCF8AE595AB5E0CF8BD11B22B392C9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_536F2AF85B40C6CB06FFD11B22B38E07" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C7DCF8AE595AB5E0CF8BD11B22B392C9" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_536F2AF85B40C6CB06FFD11B22B38E07" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_7ADDB03A6F588FE8DCEBD11B22B3E8D0" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C7DCF8AE595AB5E0CF8BD11B22B392C9" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_7ADDB03A6F588FE8DCEBD11B22B3E8D0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_E5E32FB74EBB3920F51FD11B22B31534" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C7DCF8AE595AB5E0CF8BD11B22B392C9" xlink:to="loc_us-gaap_DeferredRevenueCurrent_E5E32FB74EBB3920F51FD11B22B31534" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_D55C3C027E7878E298CDD11B22B39670" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C7DCF8AE595AB5E0CF8BD11B22B392C9" xlink:to="loc_us-gaap_NotesPayableCurrent_D55C3C027E7878E298CDD11B22B39670" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_A04E59A22F95E3E38397D11B22B4AD5C" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C7DCF8AE595AB5E0CF8BD11B22B392C9" xlink:to="loc_us-gaap_LinesOfCreditCurrent_A04E59A22F95E3E38397D11B22B4AD5C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_30A87A1BEDE662265E65D11B22B48096" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C7DCF8AE595AB5E0CF8BD11B22B392C9" xlink:to="loc_us-gaap_LiabilitiesCurrent_30A87A1BEDE662265E65D11B22B48096" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_99037AFE225EC47641B1D11B22B4B946" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_99037AFE225EC47641B1D11B22B4B946" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_BA302B41562F4032640ED11B22B4B06F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_BA302B41562F4032640ED11B22B4B06F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaap_LongTermLineOfCredit_F6736DA90D1AA606C8D7D11B22B43C39" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:to="loc_us-gaap_LongTermLineOfCredit_F6736DA90D1AA606C8D7D11B22B43C39" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_B6DD6DD7163E0438BE7DD11B22B45769" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:to="loc_us-gaap_DerivativeLiabilities_B6DD6DD7163E0438BE7DD11B22B45769" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_3BB6C1F504D415D5DE67D11B22B41EE2" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:to="loc_us-gaap_Liabilities_3BB6C1F504D415D5DE67D11B22B41EE2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_710A28F8034EFB6DD3B2D11B22B48E4F" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:to="loc_us-gaap_StockholdersEquityAbstract_710A28F8034EFB6DD3B2D11B22B48E4F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_2F4689FAAC9C41CBE9D3D11B22B46AA8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_710A28F8034EFB6DD3B2D11B22B48E4F" xlink:to="loc_us-gaap_PreferredStockValue_2F4689FAAC9C41CBE9D3D11B22B46AA8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_E1AF596A7ABDFEA82D42D11B22B4C272" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_710A28F8034EFB6DD3B2D11B22B48E4F" xlink:to="loc_us-gaap_CommonStockValue_E1AF596A7ABDFEA82D42D11B22B4C272" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_65678E6BE44CE8159403D11B22B43257" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_710A28F8034EFB6DD3B2D11B22B48E4F" xlink:to="loc_us-gaap_AdditionalPaidInCapital_65678E6BE44CE8159403D11B22B43257" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_FF31BF032DD994C7DADCD11B22B4D49F" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_710A28F8034EFB6DD3B2D11B22B48E4F" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_FF31BF032DD994C7DADCD11B22B4D49F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_A4FE01FFA04EF66844DBD11B22B4C50D" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_710A28F8034EFB6DD3B2D11B22B48E4F" xlink:to="loc_us-gaap_StockholdersEquity_A4FE01FFA04EF66844DBD11B22B4C50D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_C590C04D8FAF0498EA2DD11B22B4B293" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93B45DBD59E2FFCC1902D11B22B372FE" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_C590C04D8FAF0498EA2DD11B22B4B293" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_B28B3850D3DA41F6D43ECF75D3A524A7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9D280929B8ED11DBBB63CF75D3A5B5C2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_B28B3850D3DA41F6D43ECF75D3A524A7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9D280929B8ED11DBBB63CF75D3A5B5C2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_BD5953DFA63DCED7C018CF75D3A55553" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9D280929B8ED11DBBB63CF75D3A5B5C2" xlink:to="loc_us-gaap_NetIncomeLoss_BD5953DFA63DCED7C018CF75D3A55553" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9D280929B8ED11DBBB63CF75D3A5B5C2" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_92BBC53A970A53B029A5CF75D3A510BB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_us-gaap_Depreciation_92BBC53A970A53B029A5CF75D3A510BB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaap_AdjustmentForAmortization_CF3BD1EA756FF10B0434CF75D3A65AD5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_us-gaap_AdjustmentForAmortization_CF3BD1EA756FF10B0434CF75D3A65AD5" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationConsulting" xlink:label="loc_cgix_ShareBasedCompensationConsulting_CC3E86E868B2A38FBC37CF75D3A6B656" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_cgix_ShareBasedCompensationConsulting_CC3E86E868B2A38FBC37CF75D3A6B656" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationResearchAndDevelopment" xlink:label="loc_cgix_ShareBasedCompensationResearchAndDevelopment_E2F5944645CED337BFAACF75D3A6FCC1" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_cgix_ShareBasedCompensationResearchAndDevelopment_E2F5944645CED337BFAACF75D3A6FCC1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_1D86B2DDE0111C49A71ECF75D3A6359F" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_1D86B2DDE0111C49A71ECF75D3A6359F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_B9CF76C70903370C4628CF75D3A60E6E" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_B9CF76C70903370C4628CF75D3A60E6E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaap_AccretionExpense_16B579DE6309BD5E39C2CF75D3A6D073" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_us-gaap_AccretionExpense_16B579DE6309BD5E39C2CF75D3A6D073" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_IncreaseDecreaseDeferredRentExpense" xlink:label="loc_cgix_IncreaseDecreaseDeferredRentExpense_C4A6B0743C824B2808F5CF75D3A6F212" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_cgix_IncreaseDecreaseDeferredRentExpense_C4A6B0743C824B2808F5CF75D3A6F212" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_573ACE614AF4F68707D1CF75D3A66BF4" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_573ACE614AF4F68707D1CF75D3A66BF4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAmortizationOfDeferredCharges" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_8F4239B971A406C16D3BCF75D3A69521" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_8F4239B971A406C16D3BCF75D3A69521" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_GainLossOnConversionOfDebt" xlink:label="loc_cgix_GainLossOnConversionOfDebt_E66C5E7DFE9CC58D375CCF75D3A6D285" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_180B75FC8259BCB93E85CF75D3A57C29" xlink:to="loc_cgix_GainLossOnConversionOfDebt_E66C5E7DFE9CC58D375CCF75D3A6D285" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C2C9F94D45E80742282DCF75D3A6D7C5" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9D280929B8ED11DBBB63CF75D3A5B5C2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C2C9F94D45E80742282DCF75D3A6D7C5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8DE99C9E314A60CA34F0CF75D3A63B84" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C2C9F94D45E80742282DCF75D3A6D7C5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8DE99C9E314A60CA34F0CF75D3A63B84" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_81957DB45050585D9E6ECF75D3A6FF0A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C2C9F94D45E80742282DCF75D3A6D7C5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_81957DB45050585D9E6ECF75D3A6FF0A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_C4FC29C6C8D97173EF48CF75D3A6F813" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C2C9F94D45E80742282DCF75D3A6D7C5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_C4FC29C6C8D97173EF48CF75D3A6F813" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7D4888BEB2CA9EA52B13CF75D3A6664F" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C2C9F94D45E80742282DCF75D3A6D7C5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7D4888BEB2CA9EA52B13CF75D3A6664F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3732CEEEF0FF8F43C7D1CF75D3A71479" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_B28B3850D3DA41F6D43ECF75D3A524A7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3732CEEEF0FF8F43C7D1CF75D3A71479" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_24AD2A046A3FFD85A55DCF75D3A7F47A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3732CEEEF0FF8F43C7D1CF75D3A71479" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_24AD2A046A3FFD85A55DCF75D3A7F47A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCash" xlink:label="loc_us-gaap_IncreaseDecreaseInRestrictedCash_FDD2D438568D2BA50289CF75D3A72FFC" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3732CEEEF0FF8F43C7D1CF75D3A71479" xlink:to="loc_us-gaap_IncreaseDecreaseInRestrictedCash_FDD2D438568D2BA50289CF75D3A72FFC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_7DED95A90A72CF3BD0A1CF75D3A74B6C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3732CEEEF0FF8F43C7D1CF75D3A71479" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_7DED95A90A72CF3BD0A1CF75D3A74B6C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2668431138B0F1A5D65CF75D3A7893E" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3732CEEEF0FF8F43C7D1CF75D3A71479" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D2668431138B0F1A5D65CF75D3A7893E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_FFC0106795FE4D41E2A6CF75D3A74033" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_B28B3850D3DA41F6D43ECF75D3A524A7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_FFC0106795FE4D41E2A6CF75D3A74033" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_531B37584772C2A2D098CF75D3A7ACB5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_FFC0106795FE4D41E2A6CF75D3A74033" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_531B37584772C2A2D098CF75D3A7ACB5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_78171727702D41833C0ACF75D3A7C6C5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_FFC0106795FE4D41E2A6CF75D3A74033" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_78171727702D41833C0ACF75D3A7C6C5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_858A653D867A8F6AAFCCCF75D3A73DD0" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_FFC0106795FE4D41E2A6CF75D3A74033" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_858A653D867A8F6AAFCCCF75D3A73DD0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_D2C6D6678F40BA2EA8CCCF75D3A7DE42" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_FFC0106795FE4D41E2A6CF75D3A74033" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_D2C6D6678F40BA2EA8CCCF75D3A7DE42" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_658BB38FA616A38323FCCF75D3A7BC4B" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_FFC0106795FE4D41E2A6CF75D3A74033" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_658BB38FA616A38323FCCF75D3A7BC4B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_3B1275D0B179ECEA7330CF75D3A7A625" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_FFC0106795FE4D41E2A6CF75D3A74033" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_3B1275D0B179ECEA7330CF75D3A7A625" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3CC4ED78660DE729550FCF75D3A77C4F" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_FFC0106795FE4D41E2A6CF75D3A74033" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3CC4ED78660DE729550FCF75D3A77C4F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_B236CAA7047613580665CF75D3A72F1B" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_B28B3850D3DA41F6D43ECF75D3A524A7" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_B236CAA7047613580665CF75D3A72F1B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_712356E8BFA52174CF05CF75D3A83CEC" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_B28B3850D3DA41F6D43ECF75D3A524A7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAbstract_712356E8BFA52174CF05CF75D3A83CEC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97B1A14C80D4B1ADA3BACF75D3A82EA1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_712356E8BFA52174CF05CF75D3A83CEC" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97B1A14C80D4B1ADA3BACF75D3A82EA1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DA6CD9385F8E75C97E12CF75D3A8EEAD" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_712356E8BFA52174CF05CF75D3A83CEC" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DA6CD9385F8E75C97E12CF75D3A8EEAD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_12A1BC1477CBA0FB3584CF75D3A8F3F1" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_B28B3850D3DA41F6D43ECF75D3A524A7" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_12A1BC1477CBA0FB3584CF75D3A8F3F1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_5E905BACD1424CBC1ADACF75D3A8903A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_12A1BC1477CBA0FB3584CF75D3A8F3F1" xlink:to="loc_us-gaap_InterestPaidNet_5E905BACD1424CBC1ADACF75D3A8903A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_B28B3850D3DA41F6D43ECF75D3A524A7" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_B774C0FC026207AB9F24CF75D3A8A3E2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_B774C0FC026207AB9F24CF75D3A8A3E2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaap_PaymentsForProceedsFromShortTermInvestments_ED4CE3F12502AAA3D017CF75D3A87E2F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_us-gaap_PaymentsForProceedsFromShortTermInvestments_ED4CE3F12502AAA3D017CF75D3A87E2F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_E4607687AE290CE46824CF75D3A8DDBC" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_E4607687AE290CE46824CF75D3A8DDBC" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_CashlessExerciseOfDerivativeWarrants" xlink:label="loc_cgix_CashlessExerciseOfDerivativeWarrants_08D8FA3C7AF8BDEE416ACF75D3A82576" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_cgix_CashlessExerciseOfDerivativeWarrants_08D8FA3C7AF8BDEE416ACF75D3A82576" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_OfferingCostsDiscounted" xlink:label="loc_cgix_OfferingCostsDiscounted_AABA142540F6A1324DE6CF75D3A814F9" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_cgix_OfferingCostsDiscounted_AABA142540F6A1324DE6CF75D3A814F9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_EFC7207E8321DC201DE9CF75D3A85459" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_EFC7207E8321DC201DE9CF75D3A85459" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_UnsettledTreasuryStockRepurchases" xlink:label="loc_cgix_UnsettledTreasuryStockRepurchases_BC07EFE227BEA85B97ACCF75D3A8737D" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_cgix_UnsettledTreasuryStockRepurchases_BC07EFE227BEA85B97ACCF75D3A8737D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfFinanceReceivables" xlink:label="loc_us-gaap_ProceedsFromSaleOfFinanceReceivables_B470D342FE5898A6908DCF75D3A8C402" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_us-gaap_ProceedsFromSaleOfFinanceReceivables_B470D342FE5898A6908DCF75D3A8C402" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_73F3679F7635873D5E90CF75D3A87450" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_73F3679F7635873D5E90CF75D3A87450" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DerivativeLiabilityReclassifiedToStockholdersEquity" xlink:label="loc_cgix_DerivativeLiabilityReclassifiedToStockholdersEquity_931FC9A4DBFADA2BA35ECF75D3A93C4C" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_cgix_DerivativeLiabilityReclassifiedToStockholdersEquity_931FC9A4DBFADA2BA35ECF75D3A93C4C" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ReclassificationofDeferredOfferingCoststoAdditionalPaidinCapital" xlink:label="loc_cgix_ReclassificationofDeferredOfferingCoststoAdditionalPaidinCapital_A78BCD11391263E7A4DBCF75D3A9A7C6" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_C5928878ACF8E2579EE7CF75D3A87F99" xlink:to="loc_cgix_ReclassificationofDeferredOfferingCoststoAdditionalPaidinCapital_A78BCD11391263E7A4DBCF75D3A9A7C6" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/ConsolidatedStatementsOfOperationsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_0BD8C74E399B2C557DF8D103F5DB3DC5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_Revenues_0BD8C74E399B2C557DF8D103F5DB3DC5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_0835D35C1E27069F4F0DD103F5DC7C48" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_CostOfRevenue_0835D35C1E27069F4F0DD103F5DC7C48" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_AA0705B9D7E64B1168A7D103F5DC82C5" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_GrossProfit_AA0705B9D7E64B1168A7D103F5DC82C5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1615615C4CD047499DC6D103F5DCEF4C" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1615615C4CD047499DC6D103F5DCEF4C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_E67DEEE2DECFB1FEAA89D103F5DD664C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1615615C4CD047499DC6D103F5DCEF4C" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_E67DEEE2DECFB1FEAA89D103F5DD664C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_CBE7350419379BAB48E8D103F5DDAFF2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1615615C4CD047499DC6D103F5DCEF4C" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_CBE7350419379BAB48E8D103F5DDAFF2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_BE436A907A3315EBC557D103F5DD1225" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1615615C4CD047499DC6D103F5DCEF4C" xlink:to="loc_us-gaap_SellingAndMarketingExpense_BE436A907A3315EBC557D103F5DD1225" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_3CBA6D60CC6B58A95EF2D103F5DDA47F" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1615615C4CD047499DC6D103F5DCEF4C" xlink:to="loc_us-gaap_OperatingExpenses_3CBA6D60CC6B58A95EF2D103F5DDA47F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1A2951ADC7A15C4CE5A7D103F5DDFD40" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_OperatingIncomeLoss_1A2951ADC7A15C4CE5A7D103F5DDFD40" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C7685B82AE1575F56817D103F5DDEFE7" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C7685B82AE1575F56817D103F5DDEFE7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_AC5C735839864772EFD8D103F5DDEE50" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C7685B82AE1575F56817D103F5DDEFE7" xlink:to="loc_us-gaap_InterestExpense_AC5C735839864772EFD8D103F5DDEE50" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_51D9CCA47A88C023FD49D103F5DD6DB1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C7685B82AE1575F56817D103F5DDEFE7" xlink:to="loc_us-gaap_InvestmentIncomeInterest_51D9CCA47A88C023FD49D103F5DD6DB1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_CE28C02BC03712394D62D103F5DD954E" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C7685B82AE1575F56817D103F5DDEFE7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_CE28C02BC03712394D62D103F5DD954E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_E6FD330A0B9F548E0141D11ABDDFA354" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C7685B82AE1575F56817D103F5DDEFE7" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_E6FD330A0B9F548E0141D11ABDDFA354" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_25871A4E64A6507A7866D103F5DD621F" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C7685B82AE1575F56817D103F5DDEFE7" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_25871A4E64A6507A7866D103F5DD621F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_FE1042574059DD7FDA75D103F5DDC976" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_FE1042574059DD7FDA75D103F5DDC976" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_CBF3DD4474F85B76AC36D103F5DE8C08" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_CBF3DD4474F85B76AC36D103F5DE8C08" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1F99834661E3E7AF2604D103F5DE8A60" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_NetIncomeLoss_1F99834661E3E7AF2604D103F5DE8A60" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_2BAE196F94114C5FDD08D103F5DE79A1" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_EarningsPerShareBasic_2BAE196F94114C5FDD08D103F5DE79A1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_210BFDE982E5E35351DCD103F5DE56C4" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_EarningsPerShareDiluted_210BFDE982E5E35351DCD103F5DE56C4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20DCF0FD6B98A91BAC47D103F5DE8889" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20DCF0FD6B98A91BAC47D103F5DE8889" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_37BC2150209F24D4F201D103F5DE88C9" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6953C53753E77D18F119D103F5DA4823" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_37BC2150209F24D4F201D103F5DE88C9" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/Contingencies" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C3C4D9AABC50DC91D244CE191C9C3FD1" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_D403C4A3FB519C163B6ACE191C9CA366" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_C3C4D9AABC50DC91D244CE191C9C3FD1" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_D403C4A3FB519C163B6ACE191C9CA366" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/DescriptionOfBusinessBasisOfPresentationAcquisitionPendingAcquisitionPublicOfferingsAndReverseStockSplits" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43297C8FDA5697E02C1BC704585EB6F7" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_60ADAA4E7941973D4415C5D1207003D7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43297C8FDA5697E02C1BC704585EB6F7" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_60ADAA4E7941973D4415C5D1207003D7" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/DescriptionOfBusinessBasisOfPresentationPendingAcquisitionPublicOfferingsAndReverseStockSplitsAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_C52A2172BA4E51E185ABD0BC05979544" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_C52A2172BA4E51E185ABD0BC05979544" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_35333D37358C71486C83D0BC059705C7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_35333D37358C71486C83D0BC059705C7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_91EFD2A3C3E39C4948DBD0BC05977C12" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_35333D37358C71486C83D0BC059705C7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_91EFD2A3C3E39C4948DBD0BC05977C12" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_680A0449AD15B999DAE4D0BC059833E8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_91EFD2A3C3E39C4948DBD0BC05977C12" xlink:to="loc_us-gaap_SubsequentEventMember_680A0449AD15B999DAE4D0BC059833E8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_E6C12F550756EEAB83B5D0BC0598FF6D" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_E6C12F550756EEAB83B5D0BC0598FF6D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_294EF90772E79DF05E48D0BC0598A750" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_E6C12F550756EEAB83B5D0BC0598FF6D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_294EF90772E79DF05E48D0BC0598A750" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_GentrisCorporationMember" xlink:label="loc_cgix_GentrisCorporationMember_91374D9F9047A5863E0DD0BC05989679" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_294EF90772E79DF05E48D0BC0598A750" xlink:to="loc_cgix_GentrisCorporationMember_91374D9F9047A5863E0DD0BC05989679" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_BioServeBiotechnologiesIndiaPrivateLimitedMember" xlink:label="loc_cgix_BioServeBiotechnologiesIndiaPrivateLimitedMember_87D7B6E0BBE2C8A6DEA6D0BC0598A047" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_294EF90772E79DF05E48D0BC0598A750" xlink:to="loc_cgix_BioServeBiotechnologiesIndiaPrivateLimitedMember_87D7B6E0BBE2C8A6DEA6D0BC0598A047" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_1210C933313FFAEACAFFD0BC059874A7" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:to="loc_us-gaap_RangeAxis_1210C933313FFAEACAFFD0BC059874A7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_80DE7C23403435F0B920D0BC059865E0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_1210C933313FFAEACAFFD0BC059874A7" xlink:to="loc_us-gaap_RangeMember_80DE7C23403435F0B920D0BC059865E0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_792848F782A039044D4BD0BC05986DDC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_80DE7C23403435F0B920D0BC059865E0" xlink:to="loc_us-gaap_MinimumMember_792848F782A039044D4BD0BC05986DDC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_7D013307E7814A66C0F7D0BC05989CE6" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_80DE7C23403435F0B920D0BC059865E0" xlink:to="loc_us-gaap_MaximumMember_7D013307E7814A66C0F7D0BC05989CE6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_83AC3659D49602D944AAD0BC0598FC40" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_83AC3659D49602D944AAD0BC0598FC40" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_EBD8DD072B3BC408228DD0BC05983153" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_83AC3659D49602D944AAD0BC0598FC40" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_EBD8DD072B3BC408228DD0BC05983153" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_F118FB092327C009EACED0BC0598DE95" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_EBD8DD072B3BC408228DD0BC05983153" xlink:to="loc_us-gaap_CommonStockMember_F118FB092327C009EACED0BC0598DE95" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_07F7EA4ED8812EE0BA85D0BC0598A9B3" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_07F7EA4ED8812EE0BA85D0BC0598A9B3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_826501046D623BAE21ACD0BC059848CF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_07F7EA4ED8812EE0BA85D0BC0598A9B3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_826501046D623BAE21ACD0BC059848CF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_B58BC3C6D04910E2BEC6D0BC0599EC38" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_826501046D623BAE21ACD0BC059848CF" xlink:to="loc_us-gaap_OtherAssetsMember_B58BC3C6D04910E2BEC6D0BC0599EC38" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_A9C6526A370484A84F95D0BC0599D151" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_A9C6526A370484A84F95D0BC0599D151" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4745D33EEADCFDBF3F1DD0BC0599BF2A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_A9C6526A370484A84F95D0BC0599D151" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4745D33EEADCFDBF3F1DD0BC0599BF2A" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_AgreementOneMember" xlink:label="loc_cgix_AgreementOneMember_AAA4B3A72080790B5EF1D0BC05998258" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4745D33EEADCFDBF3F1DD0BC0599BF2A" xlink:to="loc_cgix_AgreementOneMember_AAA4B3A72080790B5EF1D0BC05998258" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_AgreementTwoMember" xlink:label="loc_cgix_AgreementTwoMember_7F084BAF24C1C6B789CFD0BC0599BE52" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4745D33EEADCFDBF3F1DD0BC0599BF2A" xlink:to="loc_cgix_AgreementTwoMember_7F084BAF24C1C6B789CFD0BC0599BE52" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_FB80F090501AA7B350FCD0BC05995B1F" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_FB80F090501AA7B350FCD0BC05995B1F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5C62C8BEAF58A6C65210D0BC05996AB8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_FB80F090501AA7B350FCD0BC05995B1F" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5C62C8BEAF58A6C65210D0BC05996AB8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_45874289ED056B4CD732D0BC0599B642" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5C62C8BEAF58A6C65210D0BC05996AB8" xlink:to="loc_us-gaap_IPOMember_45874289ED056B4CD732D0BC0599B642" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9000CD6D9F9AA48B2DBFD0BC059948CE" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D7A836EBDA857E5D760ED0BC059725B5" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9000CD6D9F9AA48B2DBFD0BC059948CE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9000CD6D9F9AA48B2DBFD0BC059948CE" xlink:to="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NumberofClinicalTrials" xlink:label="loc_cgix_NumberofClinicalTrials_5D0E22AE3F34AF6604A1D0BC0599BFB3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_cgix_NumberofClinicalTrials_5D0E22AE3F34AF6604A1D0BC0599BFB3" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_BusinessAcquisitionNumberofEmployees" xlink:label="loc_cgix_BusinessAcquisitionNumberofEmployees_668FE0713BA43ED69436D0BC05995A25" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_cgix_BusinessAcquisitionNumberofEmployees_668FE0713BA43ED69436D0BC05995A25" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_BusinessAcquisitionSquareFeetofLaboratorySpace" xlink:label="loc_cgix_BusinessAcquisitionSquareFeetofLaboratorySpace_3F2A818DEC2C4E791994D0BC0599C34F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_cgix_BusinessAcquisitionSquareFeetofLaboratorySpace_3F2A818DEC2C4E791994D0BC0599C34F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_14A83D1B74C1C94552AFD0BC05997B3D" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_14A83D1B74C1C94552AFD0BC05997B3D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_D60EBB24C5ED73789669D0BC05996358" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_D60EBB24C5ED73789669D0BC05996358" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_8B006B1C56D9597B3F2FD0BC059AD152" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_8B006B1C56D9597B3F2FD0BC059AD152" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="loc_us-gaap_NotesReceivableNet_FFF597B1CC37518EF7CAD0BF02AFC270" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_us-gaap_NotesReceivableNet_FFF597B1CC37518EF7CAD0BF02AFC270" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_LoanReceivableInterestRateStatedPercentage" xlink:label="loc_cgix_LoanReceivableInterestRateStatedPercentage_7A9D782AD5AD70D4ACB2D0BC059AFEF1" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_cgix_LoanReceivableInterestRateStatedPercentage_7A9D782AD5AD70D4ACB2D0BC059AFEF1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_BBBE2577165D99DB6105D0BC059A059A" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_BBBE2577165D99DB6105D0BC059A059A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8837E8A254541FE2137CD0BC059A0B8C" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8837E8A254541FE2137CD0BC059A0B8C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_5F3A6039830BD833082FD0BC059AF741" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_5F3A6039830BD833082FD0BC059AF741" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_BusinessCombinationContingentConsiderationArrangementsRevenuetoCalculateContingentPaymentLow" xlink:label="loc_cgix_BusinessCombinationContingentConsiderationArrangementsRevenuetoCalculateContingentPaymentLow_D652ADAE970DE7932203D0CCD2E4A12C" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_cgix_BusinessCombinationContingentConsiderationArrangementsRevenuetoCalculateContingentPaymentLow_D652ADAE970DE7932203D0CCD2E4A12C" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_BusinessCombinationContingentConsiderationArrangementsRevenuetoCalculateContingentPaymentHigh" xlink:label="loc_cgix_BusinessCombinationContingentConsiderationArrangementsRevenuetoCalculateContingentPaymentHigh_F6E2905F0C768F5D26AFD0CDB1E58392" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_cgix_BusinessCombinationContingentConsiderationArrangementsRevenuetoCalculateContingentPaymentHigh_F6E2905F0C768F5D26AFD0CDB1E58392" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_BusinessAcquisitionWeightedAverageSharePrice" xlink:label="loc_cgix_BusinessAcquisitionWeightedAverageSharePrice_9A0296E0B56E0923538ED0BC059A1B5E" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_cgix_BusinessAcquisitionWeightedAverageSharePrice_9A0296E0B56E0923538ED0BC059A1B5E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_266F30787D5164DC8C5FD0BC059A47E6" xlink:type="locator" />
    <presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_DE081C6D69D16C27C91CD0BC05999F49" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_266F30787D5164DC8C5FD0BC059A47E6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9000CD6D9F9AA48B2DBFD0BC059948CE" xlink:to="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_88969FAFEED97843C74DD0BC059A56FF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_88969FAFEED97843C74DD0BC059A56FF" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NumberOfAcquisitionAgreements" xlink:label="loc_cgix_NumberOfAcquisitionAgreements_C90369BFFE8D1F7C62A8D0BC059ADC35" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_cgix_NumberOfAcquisitionAgreements_C90369BFFE8D1F7C62A8D0BC059ADC35" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NumberOfEmployees" xlink:label="loc_cgix_NumberOfEmployees_F69FF9B0C19969449BBED0BC059A04E6" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_cgix_NumberOfEmployees_F69FF9B0C19969449BBED0BC059A04E6" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_AggregateOwnershipPercentage" xlink:label="loc_cgix_AggregateOwnershipPercentage_9CFF8826D169229A2EDAD0BC059A9A68" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_cgix_AggregateOwnershipPercentage_9CFF8826D169229A2EDAD0BC059A9A68" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_BusinessAcquisitionEquityOfAggregatePurchasePrice" xlink:label="loc_cgix_BusinessAcquisitionEquityOfAggregatePurchasePrice_8816FB6D9514AEE29C61D0BC059A7CCE" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_cgix_BusinessAcquisitionEquityOfAggregatePurchasePrice_8816FB6D9514AEE29C61D0BC059A7CCE" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_CashValueOfCommonStockShares" xlink:label="loc_cgix_CashValueOfCommonStockShares_55B688D2C15852375493D0BC059A4D4E" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_cgix_CashValueOfCommonStockShares_55B688D2C15852375493D0BC059A4D4E" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_PublicOfferingPeriod" xlink:label="loc_cgix_PublicOfferingPeriod_25F9F8AA91F6AE12A8F1D0BC059A49E3" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_cgix_PublicOfferingPeriod_25F9F8AA91F6AE12A8F1D0BC059A49E3" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_BusinessAcquisitionCashReceiptPayment" xlink:label="loc_cgix_BusinessAcquisitionCashReceiptPayment_25E04A33D0C131CF101FD0BC059BF526" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_cgix_BusinessAcquisitionCashReceiptPayment_25E04A33D0C131CF101FD0BC059BF526" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_B2638C965519FBDEF4F4D0BC059B730E" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_us-gaap_CommonStockSharesIssued_B2638C965519FBDEF4F4D0BC059B730E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AggregateIndebtedness" xlink:label="loc_us-gaap_AggregateIndebtedness_D26CF6728C7C6A0E8207D0BC059BA248" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_us-gaap_AggregateIndebtedness_D26CF6728C7C6A0E8207D0BC059BA248" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_F78201ED21E18D16E115D0BC059BF1DD" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_F78201ED21E18D16E115D0BC059BF1DD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InitialOfferingPeriod" xlink:label="loc_us-gaap_InitialOfferingPeriod_FAC336D724BD913696F1D0BC059B12C3" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationDescriptionAbstract_2A262F008ED291157F7FD0BC059A4B9E" xlink:to="loc_us-gaap_InitialOfferingPeriod_FAC336D724BD913696F1D0BC059B12C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_AE11595B47141611C664D0BC059BBFB9" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_C52A2172BA4E51E185ABD0BC05979544" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_AE11595B47141611C664D0BC059BBFB9" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:href="cgix-20140630.xsd#cgix_DocumentAndEntityInformationAbstract" xlink:label="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:type="locator" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_CF01C252B0C8BF1EC1DECE191D37C92E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_DocumentType_CF01C252B0C8BF1EC1DECE191D37C92E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_F1E0E42D1F4F889815DBCE191D373301" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_AmendmentFlag_F1E0E42D1F4F889815DBCE191D373301" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_34B6FE6DAD7B24CCED2DCE191D37E9CD" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_DocumentPeriodEndDate_34B6FE6DAD7B24CCED2DCE191D37E9CD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_6AA83C2404FC9B222A19CE191D37128E" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_DocumentFiscalYearFocus_6AA83C2404FC9B222A19CE191D37128E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0990389EFEE31C0E3581CE191D371AE1" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0990389EFEE31C0E3581CE191D371AE1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_0BEE3AD0BBAE496EB8D2CE191D37E97D" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_TradingSymbol_0BEE3AD0BBAE496EB8D2CE191D37E97D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_37274B4C93A2FD7AD48ACE191D376880" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_EntityRegistrantName_37274B4C93A2FD7AD48ACE191D376880" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_D82C24AEBE825191A872CE191D37E915" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_EntityCentralIndexKey_D82C24AEBE825191A872CE191D37E915" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8E5CEC07DB24DD119302CE191D37C9C1" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_CurrentFiscalYearEndDate_8E5CEC07DB24DD119302CE191D37C9C1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_3C4EE399359423401025CE191D372D7A" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_EntityFilerCategory_3C4EE399359423401025CE191D372D7A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_73EDD27E2F9F4C02C325CE191D3789A0" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_DocumentAndEntityInformationAbstract_12DC2469F0F89F0A5068CE191D370CE4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_73EDD27E2F9F4C02C325CE191D3789A0" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/FairValueMeasurements" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_97679A7EBE2A42AB241DCE191D09DFBD" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_FD6EC6D03D4C50ACB13DCE191D09A5C4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_97679A7EBE2A42AB241DCE191D09DFBD" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_FD6EC6D03D4C50ACB13DCE191D09A5C4" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/FairValueMeasurementsSummaryOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9E0992CACFFC6A7403B8CE191C847C17" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9E431E16099B8E6B707FCE191C844DB2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9E0992CACFFC6A7403B8CE191C847C17" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9E431E16099B8E6B707FCE191C844DB2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9314C2027DF3C871C93ACE191C8446DE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9E431E16099B8E6B707FCE191C844DB2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9314C2027DF3C871C93ACE191C8446DE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_99D085BC99E527A55864CE191C844D0C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9314C2027DF3C871C93ACE191C8446DE" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_99D085BC99E527A55864CE191C844D0C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_442197671FDE027324E4CE191C850618" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_99D085BC99E527A55864CE191C844D0C" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_442197671FDE027324E4CE191C850618" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D9648BD715F83A34E799CE191C8551E1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_99D085BC99E527A55864CE191C844D0C" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_D9648BD715F83A34E799CE191C8551E1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_AE4EC942140B6722F4ADCE191C856956" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_99D085BC99E527A55864CE191C844D0C" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_AE4EC942140B6722F4ADCE191C856956" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_E39E07344AD773C16AF7CE191C85E273" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9E431E16099B8E6B707FCE191C844DB2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_E39E07344AD773C16AF7CE191C85E273" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_54D76D824DA862CCBFEECE191C8584D5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_E39E07344AD773C16AF7CE191C85E273" xlink:to="loc_us-gaap_DerivativeLiabilities_54D76D824DA862CCBFEECE191C8584D5" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_B964BEB484C49A1801F6CE191CB03AC2" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_017E12F7E1F041F73EACCE191CB09669" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_B964BEB484C49A1801F6CE191CB03AC2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_017E12F7E1F041F73EACCE191CB09669" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrants" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3E84B71CD0C4C2596371CE191C162C78" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_BA0BC9C69FFFB2866942CE191C163C9E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3E84B71CD0C4C2596371CE191C162C78" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_BA0BC9C69FFFB2866942CE191C163C9E" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrantsAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_B5D9E78DB61C50ABBD46CE191D4E1B92" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1DA1A11CE56619877BFFCE191D4E1CE8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_B5D9E78DB61C50ABBD46CE191D4E1B92" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1DA1A11CE56619877BFFCE191D4E1CE8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_75DEEEEA5879C11B3048CE191D4EDE0B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1DA1A11CE56619877BFFCE191D4E1CE8" xlink:to="loc_us-gaap_RangeAxis_75DEEEEA5879C11B3048CE191D4EDE0B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_95930DF52B4D52B2A930CE191D4E2C41" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_75DEEEEA5879C11B3048CE191D4EDE0B" xlink:to="loc_us-gaap_RangeMember_95930DF52B4D52B2A930CE191D4E2C41" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_0806397DC98A35C1240BCE191D4EA134" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_95930DF52B4D52B2A930CE191D4E2C41" xlink:to="loc_us-gaap_MinimumMember_0806397DC98A35C1240BCE191D4EA134" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_3414788C293F62B6EC16CE191D4E070A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_95930DF52B4D52B2A930CE191D4E2C41" xlink:to="loc_us-gaap_MaximumMember_3414788C293F62B6EC16CE191D4E070A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_010D167174D76C46FDDFCE191D4E8598" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1DA1A11CE56619877BFFCE191D4E1CE8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_010D167174D76C46FDDFCE191D4E8598" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_StockPricesUsedInComputingTheFairValueOfWarrantsExercised" xlink:label="loc_cgix_StockPricesUsedInComputingTheFairValueOfWarrantsExercised_ACF389E98B98E7A813FACE191D4E00D4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_010D167174D76C46FDDFCE191D4E8598" xlink:to="loc_cgix_StockPricesUsedInComputingTheFairValueOfWarrantsExercised_ACF389E98B98E7A813FACE191D4E00D4" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_AssumptionsUsedInDeterminingFairValueOfWarrantsCommonStockPrice" xlink:label="loc_cgix_AssumptionsUsedInDeterminingFairValueOfWarrantsCommonStockPrice_3579EFB4E9BFE1EF4E40CE191D4E6F89" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_010D167174D76C46FDDFCE191D4E8598" xlink:to="loc_cgix_AssumptionsUsedInDeterminingFairValueOfWarrantsCommonStockPrice_3579EFB4E9BFE1EF4E40CE191D4E6F89" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2B1A63DE7BF55A3459ECCE191D4E847E" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_010D167174D76C46FDDFCE191D4E8598" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2B1A63DE7BF55A3459ECCE191D4E847E" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrantsAssumptionsUsedInComputingFairValueOfDerivativeWarrantsDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4C868F7426B78D132417C26E965A1E39" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_720F5977D360E92D2680C26E965A7C9F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4C868F7426B78D132417C26E965A1E39" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_720F5977D360E92D2680C26E965A7C9F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_EF627D6D3066AB7A5EACC26E965B33C0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_720F5977D360E92D2680C26E965A7C9F" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_EF627D6D3066AB7A5EACC26E965B33C0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_BAAC00FB9E9409D56E19C26E9660F471" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_EF627D6D3066AB7A5EACC26E965B33C0" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_BAAC00FB9E9409D56E19C26E9660F471" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DebtRelatedGuaranteesMember" xlink:label="loc_cgix_DebtRelatedGuaranteesMember_99CB6F59F27F4B05E5BBC26E96602794" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_BAAC00FB9E9409D56E19C26E9660F471" xlink:to="loc_cgix_DebtRelatedGuaranteesMember_99CB6F59F27F4B05E5BBC26E96602794" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ConsultantWarrantsMember" xlink:label="loc_cgix_ConsultantWarrantsMember_86CB43E7EC6EDFA4B48DC26E966083E3" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_BAAC00FB9E9409D56E19C26E9660F471" xlink:to="loc_cgix_ConsultantWarrantsMember_86CB43E7EC6EDFA4B48DC26E966083E3" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FinancialMember" xlink:label="loc_cgix_FinancialMember_A8579531191C2883043FC26E9660BC98" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_BAAC00FB9E9409D56E19C26E9660F471" xlink:to="loc_cgix_FinancialMember_A8579531191C2883043FC26E9660BC98" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7E97BA6F868FDC0573A5C26E9660FC64" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_720F5977D360E92D2680C26E965A7C9F" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7E97BA6F868FDC0573A5C26E9660FC64" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_4DC88B9C61B5DDD1B00BC26E96606E77" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7E97BA6F868FDC0573A5C26E9660FC64" xlink:to="loc_us-gaap_ClassOfStockDomain_4DC88B9C61B5DDD1B00BC26E96606E77" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5D5B727697704176A401C26E966006E5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4DC88B9C61B5DDD1B00BC26E96606E77" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5D5B727697704176A401C26E966006E5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_04C050F5B28F21C5C99CC26E96606525" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_720F5977D360E92D2680C26E965A7C9F" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_04C050F5B28F21C5C99CC26E96606525" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FairValueAssumptionExercisePrice" xlink:label="loc_cgix_FairValueAssumptionExercisePrice_A8D617744AEC0DFD7F39C26E9660DD19" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_04C050F5B28F21C5C99CC26E96606525" xlink:to="loc_cgix_FairValueAssumptionExercisePrice_A8D617744AEC0DFD7F39C26E9660DD19" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedTerm_5DCEDAD30F139D243899C26E966058EC" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_04C050F5B28F21C5C99CC26E96606525" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedTerm_5DCEDAD30F139D243899C26E966058EC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_231F0C54C5F395170E28C26E96603739" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_04C050F5B28F21C5C99CC26E96606525" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_231F0C54C5F395170E28C26E96603739" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_75ABD17B3B49A016280EC26E96602082" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_04C050F5B28F21C5C99CC26E96606525" xlink:to="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_75ABD17B3B49A016280EC26E96602082" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_732F001BF32F5FE69764C26E966070A5" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_04C050F5B28F21C5C99CC26E96606525" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_732F001BF32F5FE69764C26E966070A5" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrantsSummaryOfDerivativeWarrantActivityDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_A8CD07481E6262AF08AAD11B2102ACDC" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_B92373A57AAFAF1E37BFD11B21021971" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_A8CD07481E6262AF08AAD11B2102ACDC" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_B92373A57AAFAF1E37BFD11B21021971" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_91F0CFDA9558B557CDFDD11B21022F2A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_B92373A57AAFAF1E37BFD11B21021971" xlink:to="loc_us-gaap_StatementClassOfStockAxis_91F0CFDA9558B557CDFDD11B21022F2A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3E2D78AD4564E9EAB1B7D11B2102AE93" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_91F0CFDA9558B557CDFDD11B21022F2A" xlink:to="loc_us-gaap_ClassOfStockDomain_3E2D78AD4564E9EAB1B7D11B2102AE93" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_F5A3D18D01FE2D7FE4ACD11B210258C4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3E2D78AD4564E9EAB1B7D11B2102AE93" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_F5A3D18D01FE2D7FE4ACD11B210258C4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_2E4C3287B976EEE154CED11B2102E23D" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_B92373A57AAFAF1E37BFD11B21021971" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_2E4C3287B976EEE154CED11B2102E23D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_74603F224921D0B55889D11B21028BAA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_2E4C3287B976EEE154CED11B2102E23D" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_74603F224921D0B55889D11B21028BAA" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DebtRelatedGuaranteesMember" xlink:label="loc_cgix_DebtRelatedGuaranteesMember_9414628F5AC745F849B7D11B21022A36" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_74603F224921D0B55889D11B21028BAA" xlink:to="loc_cgix_DebtRelatedGuaranteesMember_9414628F5AC745F849B7D11B21022A36" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ConsultantWarrantsMember" xlink:label="loc_cgix_ConsultantWarrantsMember_CFF2BDCF1F34ACDB94F6D11B2102D4D8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_74603F224921D0B55889D11B21028BAA" xlink:to="loc_cgix_ConsultantWarrantsMember_CFF2BDCF1F34ACDB94F6D11B2102D4D8" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FinancialMember" xlink:label="loc_cgix_FinancialMember_D84E2CDD5DCD9DF381E8D11B210395A5" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_74603F224921D0B55889D11B21028BAA" xlink:to="loc_cgix_FinancialMember_D84E2CDD5DCD9DF381E8D11B210395A5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_AC0657F0CDC376A77F3ED11B2103D26D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_B92373A57AAFAF1E37BFD11B21021971" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_AC0657F0CDC376A77F3ED11B2103D26D" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ClassofWarrantsOutstandingRollForward" xlink:label="loc_cgix_ClassofWarrantsOutstandingRollForward_EC8463ADD5A6B07BF7A0D11B2103FE4B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_AC0657F0CDC376A77F3ED11B2103D26D" xlink:to="loc_cgix_ClassofWarrantsOutstandingRollForward_EC8463ADD5A6B07BF7A0D11B2103FE4B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_E1BA4DC4448BD4F78C50D11B2103D7CA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ClassofWarrantsOutstandingRollForward_EC8463ADD5A6B07BF7A0D11B2103FE4B" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_E1BA4DC4448BD4F78C50D11B2103D7CA" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FairValueOfWarrantsExercised" xlink:label="loc_cgix_FairValueOfWarrantsExercised_69749C62760F91F64C47D11B2103B20B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ClassofWarrantsOutstandingRollForward_EC8463ADD5A6B07BF7A0D11B2103FE4B" xlink:to="loc_cgix_FairValueOfWarrantsExercised_69749C62760F91F64C47D11B2103B20B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_DCD683200C5ECA64C3CBD11DA2BEF974" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ClassofWarrantsOutstandingRollForward_EC8463ADD5A6B07BF7A0D11B2103FE4B" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_DCD683200C5ECA64C3CBD11DA2BEF974" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_F97C41652F9CF46713A2D11B21038908" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ClassofWarrantsOutstandingRollForward_EC8463ADD5A6B07BF7A0D11B2103FE4B" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_F97C41652F9CF46713A2D11B21038908" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrantsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5CC1ED766F9AE675FAAECE191C860E3B" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_2A42579673BB73B41590CE191C86952A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5CC1ED766F9AE675FAAECE191C860E3B" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_2A42579673BB73B41590CE191C86952A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_A900588F0971BE3677E2CE191C860720" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5CC1ED766F9AE675FAAECE191C860E3B" xlink:to="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_A900588F0971BE3677E2CE191C860720" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/JointVentureAgreement" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_758AA50E5EE86BCE47EACE191D46B975" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_D02206664EB2EF88F719CE191D46F189" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_758AA50E5EE86BCE47EACE191D46B975" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_D02206664EB2EF88F719CE191D46F189" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/JointVentureAgreementAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_8B84B59A8EF8E2FA4145CAA0E47F5CBC" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_12BB47E5A5C63BF70E7FCAA0E47F27BF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_8B84B59A8EF8E2FA4145CAA0E47F5CBC" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_12BB47E5A5C63BF70E7FCAA0E47F27BF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_3E263957C36F97062DF1CAA0E47F2B16" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_12BB47E5A5C63BF70E7FCAA0E47F27BF" xlink:to="loc_dei_LegalEntityAxis_3E263957C36F97062DF1CAA0E47F2B16" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_83C9EE00EAABF786E2BECAA0E47F181A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3E263957C36F97062DF1CAA0E47F2B16" xlink:to="loc_dei_EntityDomain_83C9EE00EAABF786E2BECAA0E47F181A" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_JointVentureAgreementMember" xlink:label="loc_cgix_JointVentureAgreementMember_EAA26CB4571F42FF91AECAA0E47F56E8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_83C9EE00EAABF786E2BECAA0E47F181A" xlink:to="loc_cgix_JointVentureAgreementMember_EAA26CB4571F42FF91AECAA0E47F56E8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_5217BE3CD994DB487403CAA0E47F21B4" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_12BB47E5A5C63BF70E7FCAA0E47F27BF" xlink:to="loc_us-gaap_StatementScenarioAxis_5217BE3CD994DB487403CAA0E47F21B4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_25DAC74FA0057E6D4FF9CAA0E47F35E3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_5217BE3CD994DB487403CAA0E47F21B4" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_25DAC74FA0057E6D4FF9CAA0E47F35E3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_939DFF9798CD028B107CCB3F4EB1E004" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_25DAC74FA0057E6D4FF9CAA0E47F35E3" xlink:to="loc_us-gaap_ScenarioForecastMember_939DFF9798CD028B107CCB3F4EB1E004" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_85C69BC2AED6CEE12E78CAA0E47FE3DD" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_12BB47E5A5C63BF70E7FCAA0E47F27BF" xlink:to="loc_us-gaap_RangeAxis_85C69BC2AED6CEE12E78CAA0E47FE3DD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_0DD160882695ADB94846CAA0E47F5AE4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_85C69BC2AED6CEE12E78CAA0E47FE3DD" xlink:to="loc_us-gaap_RangeMember_0DD160882695ADB94846CAA0E47F5AE4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_17AB149BA0D8CB8A01F0CAA0E47F87D6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_0DD160882695ADB94846CAA0E47F5AE4" xlink:to="loc_us-gaap_MaximumMember_17AB149BA0D8CB8A01F0CAA0E47F87D6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_50DD691CD7B6AD3198D0CAA0E47F385E" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_12BB47E5A5C63BF70E7FCAA0E47F27BF" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_50DD691CD7B6AD3198D0CAA0E47F385E" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_JointVentureDateCommenced" xlink:label="loc_cgix_JointVentureDateCommenced_93DA9AC64638071DA1C3CAA0E47FF53A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_50DD691CD7B6AD3198D0CAA0E47F385E" xlink:to="loc_cgix_JointVentureDateCommenced_93DA9AC64638071DA1C3CAA0E47FF53A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_7D7B97FBB1C5CCDFDEADCAA0E47FD2A8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_50DD691CD7B6AD3198D0CAA0E47F385E" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_7D7B97FBB1C5CCDFDEADCAA0E47FD2A8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_CBEA94D8D1ACA15CA88ACAA0E47F1EE9" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_50DD691CD7B6AD3198D0CAA0E47F385E" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_CBEA94D8D1ACA15CA88ACAA0E47F1EE9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_FD3EC16C473CAB1797F8CAA0E480AE14" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_50DD691CD7B6AD3198D0CAA0E47F385E" xlink:to="loc_us-gaap_CommonStockSharesIssued_FD3EC16C473CAB1797F8CAA0E480AE14" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_5E7DAEDFFCAAF065F57ECAA0E48050E4" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_50DD691CD7B6AD3198D0CAA0E47F385E" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_5E7DAEDFFCAAF065F57ECAA0E48050E4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvestmentQuotedMarketValue" xlink:label="loc_us-gaap_EquityMethodInvestmentQuotedMarketValue_CF16147F56D2C9482022CAA0E480154C" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_50DD691CD7B6AD3198D0CAA0E47F385E" xlink:to="loc_us-gaap_EquityMethodInvestmentQuotedMarketValue_CF16147F56D2C9482022CAA0E480154C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/LetterOfCredit" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_351932EA2DEEC0613CBDC26A00C068CF" xlink:type="locator" />
    <loc xlink:href="cgix-20140630.xsd#cgix_StandbyLettersOfCreditTextBlock" xlink:label="loc_cgix_StandbyLettersOfCreditTextBlock_D6C1A60F243F888ED174C243A76A97AE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_351932EA2DEEC0613CBDC26A00C068CF" xlink:to="loc_cgix_StandbyLettersOfCreditTextBlock_D6C1A60F243F888ED174C243A76A97AE" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/LetterOfCreditAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_80D1EDB2B37C41EBE3C0C243A769B7F1" xlink:type="locator" />
    <loc xlink:href="cgix-20140630.xsd#cgix_LineOfCreditFacilityRestrictedAmount1" xlink:label="loc_cgix_LineOfCreditFacilityRestrictedAmount1_DB424FAE6D5362A154E6C243A769D92B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_80D1EDB2B37C41EBE3C0C243A769B7F1" xlink:to="loc_cgix_LineOfCreditFacilityRestrictedAmount1_DB424FAE6D5362A154E6C243A769D92B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_BCBA9BF39BAA01CF357BC243A76944EA" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_80D1EDB2B37C41EBE3C0C243A769B7F1" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_BCBA9BF39BAA01CF357BC243A76944EA" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/NotesPayableAndLineOfCredit" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4DE7CE2B4D547C51C65DCE191D2E6727" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_F789B30C48C193FD1012CE191D2E631A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4DE7CE2B4D547C51C65DCE191D2E6727" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_F789B30C48C193FD1012CE191D2E631A" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0327B7653674CF83EBF4C5D11FCA5BFF" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_27D77823563C01F6363EC5D11FCADFF9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0327B7653674CF83EBF4C5D11FCA5BFF" xlink:to="loc_us-gaap_DebtInstrumentTable_27D77823563C01F6363EC5D11FCADFF9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_955190CC1AB4EF3EE338C5D11FCA28EC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_27D77823563C01F6363EC5D11FCADFF9" xlink:to="loc_us-gaap_DebtInstrumentAxis_955190CC1AB4EF3EE338C5D11FCA28EC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ECCF0CC5F820433CE321C5D11FCB28A6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_955190CC1AB4EF3EE338C5D11FCA28EC" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ECCF0CC5F820433CE321C5D11FCB28A6" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WellsFargoBankMember" xlink:label="loc_cgix_WellsFargoBankMember_A2C02CAAFCA94044E592C5D11FCBAE79" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ECCF0CC5F820433CE321C5D11FCB28A6" xlink:to="loc_cgix_WellsFargoBankMember_A2C02CAAFCA94044E592C5D11FCBAE79" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_686F6399D77A1721DD7BC5D11FCB4EEF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ECCF0CC5F820433CE321C5D11FCB28A6" xlink:to="loc_us-gaap_SecuredDebtMember_686F6399D77A1721DD7BC5D11FCB4EEF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_27D77823563C01F6363EC5D11FCADFF9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_72484589E75663972307C5D11FCB0724" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_72484589E75663972307C5D11FCB0724" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_A1FA9ACFD93C1792B581C5D11FCB0FB1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_A1FA9ACFD93C1792B581C5D11FCB0FB1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_034CF1FCCAE45CFF664AC5D11FCBB50B" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_034CF1FCCAE45CFF664AC5D11FCBB50B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_9DE47FDABDBAA42B5D9FC5D11FCB8231" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_9DE47FDABDBAA42B5D9FC5D11FCB8231" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityInitiationDate1" xlink:label="loc_us-gaap_LineOfCreditFacilityInitiationDate1_D7645616E06BB08E63EBC5D11FCB0195" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:to="loc_us-gaap_LineOfCreditFacilityInitiationDate1_D7645616E06BB08E63EBC5D11FCB0195" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:label="loc_us-gaap_DebtInstrumentInterestRateAtPeriodEnd_ECF1FA15FC0F316D36DCC5D11FCBF34D" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:to="loc_us-gaap_DebtInstrumentInterestRateAtPeriodEnd_ECF1FA15FC0F316D36DCC5D11FCBF34D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_4B9847C771E06FFCA829C5D11FCBE0CD" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_4B9847C771E06FFCA829C5D11FCBE0CD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8E03A409C018C5049674C5D11FCB08FD" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8E03A409C018C5049674C5D11FCB08FD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_BD932FE35DD0A0C7C5CCC5D11FCB1003" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AF29DFBE36B6CFA1338BC5D11FCB5F99" xlink:to="loc_us-gaap_NotesPayable_BD932FE35DD0A0C7C5CCC5D11FCB1003" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditSummaryOfShortTermAndLongTermDebtObligationsDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_550D6540395BEECBB56CC5D11FD42329" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_F8702B076D3A3EF8265CC5D11FD4214A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_550D6540395BEECBB56CC5D11FD42329" xlink:to="loc_us-gaap_DebtInstrumentTable_F8702B076D3A3EF8265CC5D11FD4214A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_73F5178580DB8D9D31ADC5D11FD463C6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F8702B076D3A3EF8265CC5D11FD4214A" xlink:to="loc_us-gaap_DebtInstrumentAxis_73F5178580DB8D9D31ADC5D11FD463C6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D9BE5010A1FE2D5DF1DDC5D11FD494ED" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_73F5178580DB8D9D31ADC5D11FD463C6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D9BE5010A1FE2D5DF1DDC5D11FD494ED" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_EFAF0298A6A05B48E546C5D11FD4DB79" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D9BE5010A1FE2D5DF1DDC5D11FD494ED" xlink:to="loc_us-gaap_SecuredDebtMember_EFAF0298A6A05B48E546C5D11FD4DB79" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_698DAD9082A0D9AD7D6FC5D11FD4D2B8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F8702B076D3A3EF8265CC5D11FD4214A" xlink:to="loc_us-gaap_DebtInstrumentLineItems_698DAD9082A0D9AD7D6FC5D11FD4D2B8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_8F01D56E252FD8E81386C5D11FD4F659" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_698DAD9082A0D9AD7D6FC5D11FD4D2B8" xlink:to="loc_us-gaap_NotesPayableCurrent_8F01D56E252FD8E81386C5D11FD4F659" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_31836941C9D433C50DCAC5D11FD4FCD5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_698DAD9082A0D9AD7D6FC5D11FD4D2B8" xlink:to="loc_us-gaap_LineOfCredit_31836941C9D433C50DCAC5D11FD4FCD5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_D1E6654C9DC3D0615A57C5D11FD4513F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_698DAD9082A0D9AD7D6FC5D11FD4D2B8" xlink:to="loc_us-gaap_LinesOfCreditCurrent_D1E6654C9DC3D0615A57C5D11FD4513F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaap_LongTermLineOfCredit_A00C7CFACBC84B66353CC5D11FD4E755" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_698DAD9082A0D9AD7D6FC5D11FD4D2B8" xlink:to="loc_us-gaap_LongTermLineOfCredit_A00C7CFACBC84B66353CC5D11FD4E755" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3FCFCAE9A8126276E3FFCE191C22DA91" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_F920299F711CDE2D2B15CE191C228E1A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3FCFCAE9A8126276E3FFCE191C22DA91" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_F920299F711CDE2D2B15CE191C228E1A" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/RelatedPartyTransactions" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_28C183E206DA61797B1CCE191D6ABCBE" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_D4BE03A99290AC974466CE191D6A76E5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_28C183E206DA61797B1CCE191D6ABCBE" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_D4BE03A99290AC974466CE191D6A76E5" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/RelatedPartyTransactionsAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_06956DD73D7A11AA4AADD0BC0437A12E" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_C2F019DE42239260A512D0BC0437C7D5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_06956DD73D7A11AA4AADD0BC0437A12E" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_C2F019DE42239260A512D0BC0437C7D5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_3A0A89B3448E226E634AD0C0FE9A3818" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_C2F019DE42239260A512D0BC0437C7D5" xlink:to="loc_us-gaap_AwardTypeAxis_3A0A89B3448E226E634AD0C0FE9A3818" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0609E69CF5CB37DF37A1D0C0FEA29940" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3A0A89B3448E226E634AD0C0FE9A3818" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0609E69CF5CB37DF37A1D0C0FEA29940" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_6BD27252E1D2B9A56BEFD0C12C298120" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0609E69CF5CB37DF37A1D0C0FEA29940" xlink:to="loc_us-gaap_RestrictedStockMember_6BD27252E1D2B9A56BEFD0C12C298120" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_5C6E5322F255BF886353D0BC0438FEC4" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_C2F019DE42239260A512D0BC0437C7D5" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_5C6E5322F255BF886353D0BC0438FEC4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_97C90956988F81AB1B33D0BC0438FF35" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5C6E5322F255BF886353D0BC0438FEC4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_97C90956988F81AB1B33D0BC0438FF35" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_CompensationforServingasChairmanofBoardMember" xlink:label="loc_cgix_CompensationforServingasChairmanofBoardMember_9B011CBB10043105F925D0BC0438C80A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97C90956988F81AB1B33D0BC0438FF35" xlink:to="loc_cgix_CompensationforServingasChairmanofBoardMember_9B011CBB10043105F925D0BC0438C80A" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ConsultingandAdvisoryAgreementMember" xlink:label="loc_cgix_ConsultingandAdvisoryAgreementMember_81B77EB1DD85A58241BED0C5E2CBB9DE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97C90956988F81AB1B33D0BC0438FF35" xlink:to="loc_cgix_ConsultingandAdvisoryAgreementMember_81B77EB1DD85A58241BED0C5E2CBB9DE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40384BDEF4E6CC44E4ADD0BC04382A92" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_C2F019DE42239260A512D0BC0437C7D5" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40384BDEF4E6CC44E4ADD0BC04382A92" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_2D7890B5D5A8E878F120D0BC0438231B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40384BDEF4E6CC44E4ADD0BC04382A92" xlink:to="loc_us-gaap_RelatedPartyDomain_2D7890B5D5A8E878F120D0BC0438231B" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_JohnPappajohnMember" xlink:label="loc_cgix_JohnPappajohnMember_934FEFB51787A2B7DDFAD0BC04380485" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2D7890B5D5A8E878F120D0BC0438231B" xlink:to="loc_cgix_JohnPappajohnMember_934FEFB51787A2B7DDFAD0BC04380485" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="loc_us-gaap_BoardOfDirectorsChairmanMember_97ADECE051C80F55CFBCD0BC043868E4" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2D7890B5D5A8E878F120D0BC0438231B" xlink:to="loc_us-gaap_BoardOfDirectorsChairmanMember_97ADECE051C80F55CFBCD0BC043868E4" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_Dr.ChagantiMember" xlink:label="loc_cgix_Dr.ChagantiMember_00F7E90E28C4F6F39BDBD0BC04387006" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2D7890B5D5A8E878F120D0BC0438231B" xlink:to="loc_cgix_Dr.ChagantiMember_00F7E90E28C4F6F39BDBD0BC04387006" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_EquityDynamicsInc.Member" xlink:label="loc_cgix_EquityDynamicsInc.Member_6F565EDA6C05FF716E03D0BC0439A0EC" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2D7890B5D5A8E878F120D0BC0438231B" xlink:to="loc_cgix_EquityDynamicsInc.Member_6F565EDA6C05FF716E03D0BC0439A0EC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_A615A75344FA4801E51BD0BC0439C533" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_C2F019DE42239260A512D0BC0437C7D5" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_A615A75344FA4801E51BD0BC0439C533" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_D7A074DE0B0BC4B8490DD0BC04396C4E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_A615A75344FA4801E51BD0BC0439C533" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_D7A074DE0B0BC4B8490DD0BC04396C4E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_864B25265153E2A7051CD0BC04397E71" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_D7A074DE0B0BC4B8490DD0BC04396C4E" xlink:to="loc_us-gaap_IPOMember_864B25265153E2A7051CD0BC04397E71" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_927047440EDC49430DE8D0BC04396144" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_C2F019DE42239260A512D0BC0437C7D5" xlink:to="loc_us-gaap_PlanNameAxis_927047440EDC49430DE8D0BC04396144" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_066754FCBDCFD8A13206D0BC0439EF04" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_927047440EDC49430DE8D0BC04396144" xlink:to="loc_us-gaap_PlanNameDomain_066754FCBDCFD8A13206D0BC0439EF04" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_TwoThousandElevenEquityPlanMember" xlink:label="loc_cgix_TwoThousandElevenEquityPlanMember_64491F180B23712C44B3D0BC043982D0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_066754FCBDCFD8A13206D0BC0439EF04" xlink:to="loc_cgix_TwoThousandElevenEquityPlanMember_64491F180B23712C44B3D0BC043982D0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_F501E60C6D5792D4EA06D0BC0439C0CB" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_C2F019DE42239260A512D0BC0437C7D5" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_F501E60C6D5792D4EA06D0BC0439C0CB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_113AA08BABDB8477BDF8D0BC043EB394" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_F501E60C6D5792D4EA06D0BC0439C0CB" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_113AA08BABDB8477BDF8D0BC043EB394" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialGuaranteeMember" xlink:label="loc_us-gaap_FinancialGuaranteeMember_67BA28E79BC1ED7492A1D0BC043F27EA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_113AA08BABDB8477BDF8D0BC043EB394" xlink:to="loc_us-gaap_FinancialGuaranteeMember_67BA28E79BC1ED7492A1D0BC043F27EA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_C2F019DE42239260A512D0BC0437C7D5" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NumberOfExtensionsOfRevolvingCreditFacility" xlink:label="loc_cgix_NumberOfExtensionsOfRevolvingCreditFacility_C3D5A688612E6E5F858FD0BC043F7B77" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_NumberOfExtensionsOfRevolvingCreditFacility_C3D5A688612E6E5F858FD0BC043F7B77" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WarrantsIssuedToPurchaseCommonStockShares" xlink:label="loc_cgix_WarrantsIssuedToPurchaseCommonStockShares_6E9959A61993AE5261B1D0BC043F0A3A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_WarrantsIssuedToPurchaseCommonStockShares_6E9959A61993AE5261B1D0BC043F0A3A" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ClassOfWarrantOrRightExercised" xlink:label="loc_cgix_ClassOfWarrantOrRightExercised_15F26FE30922E1D704ADD0BC043F00BA" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_ClassOfWarrantOrRightExercised_15F26FE30922E1D704ADD0BC043F00BA" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WarrantsCommonStockSharesExercisableAdjusted" xlink:label="loc_cgix_WarrantsCommonStockSharesExercisableAdjusted_3D357706F395E55BE5A5D0BC043F3521" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_WarrantsCommonStockSharesExercisableAdjusted_3D357706F395E55BE5A5D0BC043F3521" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ClassOfWarrantOrRightOutstandingPerShare" xlink:label="loc_cgix_ClassOfWarrantOrRightOutstandingPerShare_E57EBAD9DBCD98A0789AD0BC043FD3C9" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_ClassOfWarrantOrRightOutstandingPerShare_E57EBAD9DBCD98A0789AD0BC043FD3C9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_0955C3FAB000A12C3B1DD0BC043F998A" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_0955C3FAB000A12C3B1DD0BC043F998A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_4CE92331007F7A8539CAD0BC043FE73B" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_CommonStockSharesIssued_4CE92331007F7A8539CAD0BC043FE73B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_7898521DB90741BBEEAED0BC043F8B64" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_7898521DB90741BBEEAED0BC043F8B64" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionTermsAndMannerOfSettlement" xlink:label="loc_us-gaap_RelatedPartyTransactionTermsAndMannerOfSettlement_4C309156D4873D8BDB8AD0BC043F9A6E" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_RelatedPartyTransactionTermsAndMannerOfSettlement_4C309156D4873D8BDB8AD0BC043F9A6E" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_RelatedPartyTransactionCompensationforServingasChairmanoftheBoardAnnualAmount" xlink:label="loc_cgix_RelatedPartyTransactionCompensationforServingasChairmanoftheBoardAnnualAmount_FCE38C04F464840660CED0BC043FFD68" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_RelatedPartyTransactionCompensationforServingasChairmanoftheBoardAnnualAmount_FCE38C04F464840660CED0BC043FFD68" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1FCAA382944EE069AA2CD0C0D1111BD9" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1FCAA382944EE069AA2CD0C0D1111BD9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4A6B07C0CE7E6E1F82EDD0CA2074F49D" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4A6B07C0CE7E6E1F82EDD0CA2074F49D" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_EffectiveAppointmentDate" xlink:label="loc_cgix_EffectiveAppointmentDate_C883F30C7A6CC2CF5CA8D0BC043FEAF2" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_EffectiveAppointmentDate_C883F30C7A6CC2CF5CA8D0BC043FEAF2" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_OptionGrantedPeriod" xlink:label="loc_cgix_OptionGrantedPeriod_0A68B4CD5893CC473A53D0BC043F8EC7" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_OptionGrantedPeriod_0A68B4CD5893CC473A53D0BC043F8EC7" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingNumberofInstallments" xlink:label="loc_cgix_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingNumberofInstallments_DC62689D11CE95C80EF9D0BC043F14A2" xlink:type="locator" />
    <presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingNumberofInstallments_DC62689D11CE95C80EF9D0BC043F14A2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_9FA548FB46CC52ED5813D0BC0440725F" xlink:type="locator" />
    <presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_9FA548FB46CC52ED5813D0BC0440725F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_7E3D3AA3B1E75275C498D0BC0440E0EE" xlink:type="locator" />
    <presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_7E3D3AA3B1E75275C498D0BC0440E0EE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_AB9B44F752DEF73A440ED0BC0440A562" xlink:type="locator" />
    <presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_AB9B44F752DEF73A440ED0BC0440A562" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseRelatedParty" xlink:label="loc_us-gaap_InterestExpenseRelatedParty_5E793FCF08622DE40944D0BC0440F451" xlink:type="locator" />
    <presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_InterestExpenseRelatedParty_5E793FCF08622DE40944D0BC0440F451" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ConvertibleNumberOfCommonShares" xlink:label="loc_cgix_ConvertibleNumberOfCommonShares_F1E0D8F01A4BABC1B179D0BC04401034" xlink:type="locator" />
    <presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_ConvertibleNumberOfCommonShares_F1E0D8F01A4BABC1B179D0BC04401034" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_CommonStockIssuedUponConversionConversionPricePerShare" xlink:label="loc_cgix_CommonStockIssuedUponConversionConversionPricePerShare_C5D7C0E6917B2DADD2EED0BC04406A5E" xlink:type="locator" />
    <presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_CommonStockIssuedUponConversionConversionPricePerShare_C5D7C0E6917B2DADD2EED0BC04406A5E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesHeldInEmployeeStockOptionPlanAllocated" xlink:label="loc_us-gaap_SharesHeldInEmployeeStockOptionPlanAllocated_97F2E5A6E6423AC5BA12D0BC0440F31B" xlink:type="locator" />
    <presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_SharesHeldInEmployeeStockOptionPlanAllocated_97F2E5A6E6423AC5BA12D0BC0440F31B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_756AA10F22A42E8C79A4D0BC044002D2" xlink:type="locator" />
    <presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_SharePrice_756AA10F22A42E8C79A4D0BC044002D2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_33B9BB4A3F033E2259B8D0BC0440FB2B" xlink:type="locator" />
    <presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_33B9BB4A3F033E2259B8D0BC0440FB2B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaap_StockOptionPlanExpense_3C7930847BE65E9376A9D0BC04408257" xlink:type="locator" />
    <presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_StockOptionPlanExpense_3C7930847BE65E9376A9D0BC04408257" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ConsultingAgreementPeriod" xlink:label="loc_cgix_ConsultingAgreementPeriod_A61B1142BFB3A62FF818D0BC044062E3" xlink:type="locator" />
    <presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_ConsultingAgreementPeriod_A61B1142BFB3A62FF818D0BC044062E3" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_RelatedPartyTransactionManagementAdvisoryFee" xlink:label="loc_cgix_RelatedPartyTransactionManagementAdvisoryFee_A5DA3AC06EF774D20F06D0BC04404796" xlink:type="locator" />
    <presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_RelatedPartyTransactionManagementAdvisoryFee_A5DA3AC06EF774D20F06D0BC04404796" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_B9E6D78ACCCC18AE1E13D0BC04404B42" xlink:type="locator" />
    <presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_B9E6D78ACCCC18AE1E13D0BC04404B42" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_04A78C63E0C21536AC10D0BC04401738" xlink:type="locator" />
    <presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_04A78C63E0C21536AC10D0BC04401738" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_RelatedPartyTransactionOneTimePaymentForRight" xlink:label="loc_cgix_RelatedPartyTransactionOneTimePaymentForRight_BCA8ED3CCD7FE8F443DBD0BC04401A21" xlink:type="locator" />
    <presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_RelatedPartyTransactionOneTimePaymentForRight_BCA8ED3CCD7FE8F443DBD0BC04401A21" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ConsiderationPercentageOfFuturePotentialRevenuesFromRelatedParty" xlink:label="loc_cgix_ConsiderationPercentageOfFuturePotentialRevenuesFromRelatedParty_4148A930B640FB876D4DD0BC04409AAB" xlink:type="locator" />
    <presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_ConsiderationPercentageOfFuturePotentialRevenuesFromRelatedParty_4148A930B640FB876D4DD0BC04409AAB" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_PatentExpenses" xlink:label="loc_cgix_PatentExpenses_92161CD5A1EBFC6081BBD0BC044002D3" xlink:type="locator" />
    <presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_PatentExpenses_92161CD5A1EBFC6081BBD0BC044002D3" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NumberOfPatents" xlink:label="loc_cgix_NumberOfPatents_CD42D9BF2F2A7905EA7DD0BC04418954" xlink:type="locator" />
    <presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_NumberOfPatents_CD42D9BF2F2A7905EA7DD0BC04418954" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_RelatedPartyConsultingFees" xlink:label="loc_cgix_RelatedPartyConsultingFees_DB1B0A28B95E5AA6F9E6D0BC04414D15" xlink:type="locator" />
    <presentationArc order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_cgix_RelatedPartyConsultingFees_DB1B0A28B95E5AA6F9E6D0BC04414D15" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_BFF704EDC6DA558C276AD0BC04416CAD" xlink:type="locator" />
    <presentationArc order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_DF3C56FCFF928423B7A4D0BC043F7B13" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_BFF704EDC6DA558C276AD0BC04416CAD" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivable" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaap_ReceivablesAbstract_47DB5386AB6113DC19ACC70529CD6877" xlink:type="locator" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NetRevenuesAndAccountsReceivableTextBlock" xlink:label="loc_cgix_NetRevenuesAndAccountsReceivableTextBlock_355A3679E6698541C373C5D120062E66" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_47DB5386AB6113DC19ACC70529CD6877" xlink:to="loc_cgix_NetRevenuesAndAccountsReceivableTextBlock_355A3679E6698541C373C5D120062E66" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaap_ReceivablesAbstract_8C4D4300BE40B902FF05C5908487101C" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_A13495D6050C51F6079CC5908487C9B4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_8C4D4300BE40B902FF05C5908487101C" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_A13495D6050C51F6079CC5908487C9B4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3FDE4D59F1ED575F87B1C5908487A64B" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_A13495D6050C51F6079CC5908487C9B4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3FDE4D59F1ED575F87B1C5908487A64B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210A0769F33676B1666AC5908487A04A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3FDE4D59F1ED575F87B1C5908487A64B" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210A0769F33676B1666AC5908487A04A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_B267B39544D0D935E2F1C590848714F2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210A0769F33676B1666AC5908487A04A" xlink:to="loc_us-gaap_SalesMember_B267B39544D0D935E2F1C590848714F2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_B6D44E3C9A0F9B5E6173C590848763A3" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_A13495D6050C51F6079CC5908487C9B4" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_B6D44E3C9A0F9B5E6173C590848763A3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_02F2DCD7003FEB19F47DC590848759B8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_B6D44E3C9A0F9B5E6173C590848763A3" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_02F2DCD7003FEB19F47DC590848759B8" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_PhaseOneClinicalTrialMember" xlink:label="loc_cgix_PhaseOneClinicalTrialMember_A3944CD641F64D5A9B46C5908487C172" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_02F2DCD7003FEB19F47DC590848759B8" xlink:to="loc_cgix_PhaseOneClinicalTrialMember_A3944CD641F64D5A9B46C5908487C172" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_PhaseTwoClinicalTrialMember" xlink:label="loc_cgix_PhaseTwoClinicalTrialMember_AAFEF46865C108ABD316C59084884DF8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_02F2DCD7003FEB19F47DC590848759B8" xlink:to="loc_cgix_PhaseTwoClinicalTrialMember_AAFEF46865C108ABD316C59084884DF8" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_CustomerTwoMember" xlink:label="loc_cgix_CustomerTwoMember_4CCBBDEE1B9F675F9A5DC5908488986F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_02F2DCD7003FEB19F47DC590848759B8" xlink:to="loc_cgix_CustomerTwoMember_4CCBBDEE1B9F675F9A5DC5908488986F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5E1EEE74011A72816994C5908488D9AC" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_A13495D6050C51F6079CC5908487C9B4" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5E1EEE74011A72816994C5908488D9AC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaap_ReceivableTypeDomain_6F5769FFEC06DD6D0897C5908488D984" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_5E1EEE74011A72816994C5908488D9AC" xlink:to="loc_us-gaap_ReceivableTypeDomain_6F5769FFEC06DD6D0897C5908488D984" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_TenPercentOrMoreClinicalRevenueMember" xlink:label="loc_cgix_TenPercentOrMoreClinicalRevenueMember_AF1B03135785AD785A79C590848855EC" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_6F5769FFEC06DD6D0897C5908488D984" xlink:to="loc_cgix_TenPercentOrMoreClinicalRevenueMember_AF1B03135785AD785A79C590848855EC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_54990A99BBB352E031C1C59084880F1B" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_A13495D6050C51F6079CC5908487C9B4" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_54990A99BBB352E031C1C59084880F1B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_283A40F1570082433215C590848888C9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_54990A99BBB352E031C1C59084880F1B" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_283A40F1570082433215C590848888C9" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_EntityWideRevenueNumberOfSingleCustomerAccountedForMoreThanTenPercentOfRevenue" xlink:label="loc_cgix_EntityWideRevenueNumberOfSingleCustomerAccountedForMoreThanTenPercentOfRevenue_DA0DC9B374B2AA55F860C5908488DB6F" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_54990A99BBB352E031C1C59084880F1B" xlink:to="loc_cgix_EntityWideRevenueNumberOfSingleCustomerAccountedForMoreThanTenPercentOfRevenue_DA0DC9B374B2AA55F860C5908488DB6F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableScheduleOfAccountsReceivableByPayorTypeDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaap_ReceivablesAbstract_E3C52B5EAF6CED670E99C5D11FF41B05" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ED476194F9875F0A37D5C5D11FF404C1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_E3C52B5EAF6CED670E99C5D11FF41B05" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ED476194F9875F0A37D5C5D11FF404C1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_59A6E36AB648F7D354ADC5D11FF40A1D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ED476194F9875F0A37D5C5D11FF404C1" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_59A6E36AB648F7D354ADC5D11FF40A1D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_86EF1791FED969DDF13FC5D11FF49A18" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_59A6E36AB648F7D354ADC5D11FF40A1D" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_86EF1791FED969DDF13FC5D11FF49A18" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_MedicareMember" xlink:label="loc_cgix_MedicareMember_9CECE5D0169FC80F6033C5D11FF46EC9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_86EF1791FED969DDF13FC5D11FF49A18" xlink:to="loc_cgix_MedicareMember_9CECE5D0169FC80F6033C5D11FF46EC9" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DirectBillMember" xlink:label="loc_cgix_DirectBillMember_69070F867936DCD27254C5D11FF566DF" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_86EF1791FED969DDF13FC5D11FF49A18" xlink:to="loc_cgix_DirectBillMember_69070F867936DCD27254C5D11FF566DF" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_InsuranceMember" xlink:label="loc_cgix_InsuranceMember_FB1BFD160ED814D1D237C5D11FF5C1B0" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_86EF1791FED969DDF13FC5D11FF49A18" xlink:to="loc_cgix_InsuranceMember_FB1BFD160ED814D1D237C5D11FF5C1B0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_89C39BF4BA227F3E48DFC5D11FF567AA" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_ED476194F9875F0A37D5C5D11FF404C1" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_89C39BF4BA227F3E48DFC5D11FF567AA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_80566A7C1C7281BCA563C5D11FF5A446" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_89C39BF4BA227F3E48DFC5D11FF567AA" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_80566A7C1C7281BCA563C5D11FF5A446" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ACE3588E357658C284ABC5D11FF5DE98" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_89C39BF4BA227F3E48DFC5D11FF567AA" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ACE3588E357658C284ABC5D11FF5DE98" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_AC4AA71AEBE77B6D33FFC5D11FF54563" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_89C39BF4BA227F3E48DFC5D11FF567AA" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_AC4AA71AEBE77B6D33FFC5D11FF54563" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableScheduleOfRevenueByPayorTypeDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaap_ReceivablesAbstract_EACC7CE22FE1ADB21776C5D11FFDE8FA" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable" xlink:label="loc_us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable_92F312533254100A8D1FC5D11FFD0703" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_EACC7CE22FE1ADB21776C5D11FFDE8FA" xlink:to="loc_us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable_92F312533254100A8D1FC5D11FFD0703" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_3F4AC48D32AC908D0CDEC5D11FFDEDFE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable_92F312533254100A8D1FC5D11FFD0703" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_3F4AC48D32AC908D0CDEC5D11FFDEDFE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_41412CFA3259E1357464C5D11FFD84C1" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_3F4AC48D32AC908D0CDEC5D11FFDEDFE" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_41412CFA3259E1357464C5D11FFD84C1" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_MedicareMember" xlink:label="loc_cgix_MedicareMember_E5D6A3DC64ECBC9CB705C5D11FFDADFD" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_41412CFA3259E1357464C5D11FFD84C1" xlink:to="loc_cgix_MedicareMember_E5D6A3DC64ECBC9CB705C5D11FFDADFD" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DirectBillMember" xlink:label="loc_cgix_DirectBillMember_CE8FF7B870DF9C1C9348C5D11FFDE09B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_41412CFA3259E1357464C5D11FFD84C1" xlink:to="loc_cgix_DirectBillMember_CE8FF7B870DF9C1C9348C5D11FFDE09B" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_InsuranceMember" xlink:label="loc_cgix_InsuranceMember_76539145DA850415E6F3C5D11FFDF759" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_41412CFA3259E1357464C5D11FFD84C1" xlink:to="loc_cgix_InsuranceMember_76539145DA850415E6F3C5D11FFDF759" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems" xlink:label="loc_us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems_D95CBAB4048CC5AE4B9CC5D11FFDC183" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTable_92F312533254100A8D1FC5D11FFD0703" xlink:to="loc_us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems_D95CBAB4048CC5AE4B9CC5D11FFDC183" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_E86DC3619AC30A76C613C5D11FFDA102" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems_D95CBAB4048CC5AE4B9CC5D11FFDC183" xlink:to="loc_us-gaap_Revenues_E86DC3619AC30A76C613C5D11FFDA102" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaap_ReceivablesAbstract_57E1A8C92E3367B808FEC704FF601F17" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_DC3C8075C4A2C5924728C5D120048B83" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_57E1A8C92E3367B808FEC704FF601F17" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_DC3C8075C4A2C5924728C5D120048B83" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_3D54C75F7F2E3BB375C9C5D120045344" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_57E1A8C92E3367B808FEC704FF601F17" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_3D54C75F7F2E3BB375C9C5D120045344" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_080982EB4FC7EAA381D3CE191C40C63A" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6AC3CAA16AFE57D581D0CE191C407682" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_080982EB4FC7EAA381D3CE191C40C63A" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6AC3CAA16AFE57D581D0CE191C407682" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_C9D36A5EF0D98606B793C5D1202F1797" xlink:type="locator" />
    <loc xlink:href="cgix-20140630.xsd#cgix_SignificantAccountingPoliciesTable" xlink:label="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C9D36A5EF0D98606B793C5D1202F1797" xlink:to="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_816189A181B418802708C5D12030FABA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:to="loc_us-gaap_RangeAxis_816189A181B418802708C5D12030FABA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_D0EBF445D93314897B34C5D120300ECA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_816189A181B418802708C5D12030FABA" xlink:to="loc_us-gaap_RangeMember_D0EBF445D93314897B34C5D120300ECA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_C0A22771791272A618E3C5D12035C795" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_D0EBF445D93314897B34C5D120300ECA" xlink:to="loc_us-gaap_MinimumMember_C0A22771791272A618E3C5D12035C795" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_C45B3CCE7DD5F7AE2535C5D120351171" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_D0EBF445D93314897B34C5D120300ECA" xlink:to="loc_us-gaap_MaximumMember_C45B3CCE7DD5F7AE2535C5D120351171" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_43D4107F0CF22079718CC6D142875242" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:to="loc_us-gaap_StatementGeographicalAxis_43D4107F0CF22079718CC6D142875242" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_B033F84E43FE8287E0ECC6D3EC35D041" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementGeographicalAxis_43D4107F0CF22079718CC6D142875242" xlink:to="loc_us-gaap_SegmentGeographicalDomain_B033F84E43FE8287E0ECC6D3EC35D041" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_NJ" xlink:label="loc_stpr_NJ_C7161061AB09FBF47C9CC6D16D088EA5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_B033F84E43FE8287E0ECC6D3EC35D041" xlink:to="loc_stpr_NJ_C7161061AB09FBF47C9CC6D16D088EA5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4360241C612A56F94A0CC5D120352CB4" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4360241C612A56F94A0CC5D120352CB4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D4CEC83E44961B43DCA5C5D12035A2D9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4360241C612A56F94A0CC5D120352CB4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D4CEC83E44961B43DCA5C5D12035A2D9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_19EE880F80470D4EDCBBC5D1203599FE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D4CEC83E44961B43DCA5C5D12035A2D9" xlink:to="loc_us-gaap_PatentsMember_19EE880F80470D4EDCBBC5D1203599FE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_5BC4E99AE9B148A49A80C5D1203526B2" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:to="loc_us-gaap_CreditFacilityAxis_5BC4E99AE9B148A49A80C5D1203526B2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_803AF408B75BFEC18F0DC5D12035B252" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5BC4E99AE9B148A49A80C5D1203526B2" xlink:to="loc_us-gaap_CreditFacilityDomain_803AF408B75BFEC18F0DC5D12035B252" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WellsFargoBankMember" xlink:label="loc_cgix_WellsFargoBankMember_1BFB7F2EE6166E597106C5D120356935" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_803AF408B75BFEC18F0DC5D12035B252" xlink:to="loc_cgix_WellsFargoBankMember_1BFB7F2EE6166E597106C5D120356935" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_E2796666F795810E0331C5D1203553F0" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_E2796666F795810E0331C5D1203553F0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_C6F6F36FAEB4F7EA8F70C5D12035709E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_E2796666F795810E0331C5D1203553F0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_C6F6F36FAEB4F7EA8F70C5D12035709E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_DE54FE37404582356330C5D1203694A0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_C6F6F36FAEB4F7EA8F70C5D12035709E" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_DE54FE37404582356330C5D1203694A0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_87762E28099B8FDB6F7CC5D120364BD7" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_87762E28099B8FDB6F7CC5D120364BD7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_95EB0F7FDF71F47EE30AC5D120368C7E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_87762E28099B8FDB6F7CC5D120364BD7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_95EB0F7FDF71F47EE30AC5D120368C7E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_07DBFA0BBB8E0906E663C5D120369B71" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_95EB0F7FDF71F47EE30AC5D120368C7E" xlink:to="loc_us-gaap_OtherAssetsMember_07DBFA0BBB8E0906E663C5D120369B71" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_089C0D2A7ADE944E253CC5D120361D83" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_089C0D2A7ADE944E253CC5D120361D83" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_94D56734FD5D8D8C1689C5D120364FAA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_089C0D2A7ADE944E253CC5D120361D83" xlink:to="loc_us-gaap_SegmentDomain_94D56734FD5D8D8C1689C5D120364FAA" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_CancerGeneticsItaliaSrlMember" xlink:label="loc_cgix_CancerGeneticsItaliaSrlMember_6C1E21C7208D46460DCCC5D120366946" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94D56734FD5D8D8C1689C5D120364FAA" xlink:to="loc_cgix_CancerGeneticsItaliaSrlMember_6C1E21C7208D46460DCCC5D120366946" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_SignificantAccountingPoliciesLineItems" xlink:label="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesTable_E3B16E31AE9CB87588D8C5D1202FE8CF" xlink:to="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_EB9943603815A04F4C03C5D12036FF19" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_NumberOfOperatingSegments_EB9943603815A04F4C03C5D12036FF19" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_8EE73851B866F8DE069BC5D12036E7C2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_Assets_8EE73851B866F8DE069BC5D12036E7C2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_98E6BE4D2B026D5ACAD2C5D12036793F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_Revenues_98E6BE4D2B026D5ACAD2C5D12036793F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaap_LongTermLineOfCredit_74D252467BFB9F6DA683C5D12036D8F7" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_LongTermLineOfCredit_74D252467BFB9F6DA683C5D12036D8F7" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_LetterOfCreditHeldAsCollateralUnderLeaseAgreement" xlink:label="loc_cgix_LetterOfCreditHeldAsCollateralUnderLeaseAgreement_868813CAECC62DD05DD7C5D12036E22C" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_cgix_LetterOfCreditHeldAsCollateralUnderLeaseAgreement_868813CAECC62DD05DD7C5D12036E22C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9D97E6014C39A524D9D6C5D120362D63" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9D97E6014C39A524D9D6C5D120362D63" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_BEDA00CDFF3818076209C5D12036147A" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_BEDA00CDFF3818076209C5D12036147A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_A4877C501367D90D6A08C6CC69C92B8C" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_OperatingLossCarryforwards_A4877C501367D90D6A08C6CC69C92B8C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherReceivables" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherReceivables_1D00B1069E9A5BC139E4C6CFD0A11894" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherReceivables_1D00B1069E9A5BC139E4C6CFD0A11894" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_575ED354B7BC20D8C4B6C5D12036B5C3" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_575ED354B7BC20D8C4B6C5D12036B5C3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A3E78ACA66E6DBEABA2C5D1203671D3" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A3E78ACA66E6DBEABA2C5D1203671D3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1157B3E9DC50BD689B7EC5D12037F08C" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1157B3E9DC50BD689B7EC5D12037F08C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_AAF8A02513A0C96C8DCBC5D120374708" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_AAF8A02513A0C96C8DCBC5D120374708" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DueFromJointVenturesNoncurrent" xlink:label="loc_us-gaap_DueFromJointVenturesNoncurrent_97D8E3A6F2DC7239374BC5D120370BED" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_SignificantAccountingPoliciesLineItems_897490097A424197EA54C5D1203644C8" xlink:to="loc_us-gaap_DueFromJointVenturesNoncurrent_97D8E3A6F2DC7239374BC5D120370BED" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesComputationOfBasicNetIncomeLossAndDilutedNetLossPerShareDataDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4601553F8D12E9AFABE7D11B22771BD1" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_B0DBF1F87A8DDFF6B86DD11B22776BDB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4601553F8D12E9AFABE7D11B22771BD1" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_B0DBF1F87A8DDFF6B86DD11B22776BDB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_ABE8EE9027DEA4A04BBED11B2277E369" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_B0DBF1F87A8DDFF6B86DD11B22776BDB" xlink:to="loc_us-gaap_NetIncomeLoss_ABE8EE9027DEA4A04BBED11B2277E369" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DilutiveSecurities" xlink:label="loc_us-gaap_DilutiveSecurities_0D5861C4401B2F3751CCD11F2ACD1457" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_B0DBF1F87A8DDFF6B86DD11B22776BDB" xlink:to="loc_us-gaap_DilutiveSecurities_0D5861C4401B2F3751CCD11F2ACD1457" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_137E3CEE4FE8D748F2F9D1211AE9C68A" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_B0DBF1F87A8DDFF6B86DD11B22776BDB" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_137E3CEE4FE8D748F2F9D1211AE9C68A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_AEF019478D165DBE93ADD11B2277CB05" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4601553F8D12E9AFABE7D11B22771BD1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_AEF019478D165DBE93ADD11B2277CB05" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_234E53C41C1EF1D2148FD11B2277D591" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_AEF019478D165DBE93ADD11B2277CB05" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_234E53C41C1EF1D2148FD11B2277D591" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_125000565428A9D2E7DAD11B2277D15C" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_AEF019478D165DBE93ADD11B2277CB05" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_125000565428A9D2E7DAD11B2277D15C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_039863B39BB1839469CDD11B227755ED" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_125000565428A9D2E7DAD11B2277D15C" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_039863B39BB1839469CDD11B227755ED" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3FA3A86B2CAF73120B9CD11B227707C8" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_125000565428A9D2E7DAD11B2277D15C" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3FA3A86B2CAF73120B9CD11B227707C8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E45E0C5F33B937C0AACBD11B2277AF93" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_AEF019478D165DBE93ADD11B2277CB05" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E45E0C5F33B937C0AACBD11B2277AF93" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_1103168EFC07F84447A9D11B22781D16" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4601553F8D12E9AFABE7D11B22771BD1" xlink:to="loc_us-gaap_EarningsPerShareBasic_1103168EFC07F84447A9D11B22781D16" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_800E80CE7C7A84D91C09D11B2278CCCD" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4601553F8D12E9AFABE7D11B22771BD1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_800E80CE7C7A84D91C09D11B2278CCCD" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3B14B606E2FE91988459CFE8AB0A2974" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3B14B606E2FE91988459CFE8AB0A2974" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_3CBEC68782762E0458BFCFE8AB0AB438" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_3CBEC68782762E0458BFCFE8AB0AB438" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock" xlink:label="loc_us-gaap_LiquidityDisclosureTextBlock_4C26B9CC43BF345F141BCFE8AB0AC500" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_LiquidityDisclosureTextBlock_4C26B9CC43BF345F141BCFE8AB0AC500" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_EF0545EA2EADCAF76578CFE8AB0AC1AC" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_EF0545EA2EADCAF76578CFE8AB0AC1AC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_DA2D737F17E6074F0149CFE8AB0A0F36" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_UseOfEstimates_DA2D737F17E6074F0149CFE8AB0A0F36" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:label="loc_cgix_RisksAndUncertaintiesPolicyPolicyTextBlock_DC0073AEEDB747774779CFE8AB0A15B8" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_cgix_RisksAndUncertaintiesPolicyPolicyTextBlock_DC0073AEEDB747774779CFE8AB0A15B8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5D52AB784DFD3D6061FACFE8AB0A01C6" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5D52AB784DFD3D6061FACFE8AB0A01C6" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_RestrictedCashPolicyPolicyTextBlock" xlink:label="loc_cgix_RestrictedCashPolicyPolicyTextBlock_05FCA7AF8EB6E314E534CFE8AB0A4F2A" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_cgix_RestrictedCashPolicyPolicyTextBlock_05FCA7AF8EB6E314E534CFE8AB0A4F2A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_1F52E4F91888A568D1A1CFE8AB0AEC8D" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_1F52E4F91888A568D1A1CFE8AB0AEC8D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_12782699E48E2CE37421CFE8AB0BB146" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_12782699E48E2CE37421CFE8AB0BB146" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionDeferredRevenue" xlink:label="loc_us-gaap_RevenueRecognitionDeferredRevenue_44BEE32856F0E5F1D718CFE8AB0B2574" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_RevenueRecognitionDeferredRevenue_44BEE32856F0E5F1D718CFE8AB0B2574" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetRetirementObligationsPolicy" xlink:label="loc_us-gaap_AssetRetirementObligationsPolicy_8D2128083D430A557E45CFE8AB0B2A11" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_AssetRetirementObligationsPolicy_8D2128083D430A557E45CFE8AB0B2A11" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaap_DebtPolicyTextBlock_880F336A9279DAE24B77CFE8AB0B5596" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_DebtPolicyTextBlock_880F336A9279DAE24B77CFE8AB0B5596" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WarrantLiabilityPolicyPolicyTextBlock" xlink:label="loc_cgix_WarrantLiabilityPolicyPolicyTextBlock_07F97AFE6DAC34D9C720CFE8AB0B563A" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_cgix_WarrantLiabilityPolicyPolicyTextBlock_07F97AFE6DAC34D9C720CFE8AB0B563A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_E79D92C8EE9189FC1A4BCFE8AB0B0928" xlink:type="locator" />
    <presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_E79D92C8EE9189FC1A4BCFE8AB0B0928" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_B83DC60248F8ED9ABDCDCFE8AB0B2E14" xlink:type="locator" />
    <presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_B83DC60248F8ED9ABDCDCFE8AB0B2E14" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_087D5E1D31A8E3E5ACF6CFE8AB0BA40F" xlink:type="locator" />
    <presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_087D5E1D31A8E3E5ACF6CFE8AB0BA40F" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_RegistrationPaymentArrangementsPolicyPolicyTextBlock" xlink:label="loc_cgix_RegistrationPaymentArrangementsPolicyPolicyTextBlock_0CE59CA5BE726D62E3B0CFE8AB0B0441" xlink:type="locator" />
    <presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_cgix_RegistrationPaymentArrangementsPolicyPolicyTextBlock_0CE59CA5BE726D62E3B0CFE8AB0B0441" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_FD9F66B09C0E9A69ADCACFE8AB0BC4F3" xlink:type="locator" />
    <presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_FD9F66B09C0E9A69ADCACFE8AB0BC4F3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_F377FED54DD1B9A0008CCFE8AB0BDA41" xlink:type="locator" />
    <presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_F377FED54DD1B9A0008CCFE8AB0BDA41" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_7503E7138A4C0BC5802DCFE8AB0B22D2" xlink:type="locator" />
    <presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_7503E7138A4C0BC5802DCFE8AB0B22D2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_D95AB0973A753E4463B7CFE8AB0B79E3" xlink:type="locator" />
    <presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_D95AB0973A753E4463B7CFE8AB0B79E3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A47E046DD7995FAA1DDACFEAE2B0AFBE" xlink:type="locator" />
    <presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A47E046DD7995FAA1DDACFEAE2B0AFBE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_27F4A4F09A289900807BCFE8AB0BBEA8" xlink:type="locator" />
    <presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2F65862FF137D03A5DE0CFE8AB0AFB4A" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_27F4A4F09A289900807BCFE8AB0BBEA8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesSummaryOfPotentiallyDilutiveAdjustmentsToWeightedAverageNumberOfCommonSharesExcludedFromCalculationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_F73FC6DB5600AADEE84EC5D1200E9043" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_B52949639B27EEE3571CC5D1200E09EA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_F73FC6DB5600AADEE84EC5D1200E9043" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_B52949639B27EEE3571CC5D1200E09EA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_86B3F2DD036F0A323A5CC5D1200EF004" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_B52949639B27EEE3571CC5D1200E09EA" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_86B3F2DD036F0A323A5CC5D1200EF004" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1FC27ECBCF3F98A4D8F1C5D1200E6FC9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_86B3F2DD036F0A323A5CC5D1200EF004" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1FC27ECBCF3F98A4D8F1C5D1200E6FC9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_38A59013BDC0D6436CDAC5D1200E76AA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1FC27ECBCF3F98A4D8F1C5D1200E6FC9" xlink:to="loc_us-gaap_WarrantMember_38A59013BDC0D6436CDAC5D1200E76AA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_380BE0764F5D2371F638C5D1200E281B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1FC27ECBCF3F98A4D8F1C5D1200E6FC9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_380BE0764F5D2371F638C5D1200E281B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_E0506C89E67E13F5B0CDC5D1200F0EC2" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1FC27ECBCF3F98A4D8F1C5D1200E6FC9" xlink:to="loc_us-gaap_RestrictedStockMember_E0506C89E67E13F5B0CDC5D1200F0EC2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_85EC1912BD22819EED25C5D1200F1A12" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_B52949639B27EEE3571CC5D1200E09EA" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_85EC1912BD22819EED25C5D1200F1A12" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_C78D2CC3532A7DA81BA7C5D1200F49CB" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_85EC1912BD22819EED25C5D1200F1A12" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_C78D2CC3532A7DA81BA7C5D1200F49CB" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5DC80E5EF504185AA7C9CE191C59137C" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_BB7486C399F355B82818CE191C59F023" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5DC80E5EF504185AA7C9CE191C59137C" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_BB7486C399F355B82818CE191C59F023" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9EA9D353DDEE83146FFBCE191C591653" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5DC80E5EF504185AA7C9CE191C59137C" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9EA9D353DDEE83146FFBCE191C591653" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlans" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B902D068C2FC3B0A555BCE191C41337E" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_FC6F0AF2B2108D9A3A8BCE191C410E9C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B902D068C2FC3B0A555BCE191C41337E" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_FC6F0AF2B2108D9A3A8BCE191C410E9C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1C4C8FE5114AC5681325C5D11F8AD2C3" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06F4D5A038B424BC1FF3C5D11F8AC691" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1C4C8FE5114AC5681325C5D11F8AD2C3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06F4D5A038B424BC1FF3C5D11F8AC691" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_E336D04120BAA47B2DA0C5D11F8A0B92" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06F4D5A038B424BC1FF3C5D11F8AC691" xlink:to="loc_us-gaap_AwardTypeAxis_E336D04120BAA47B2DA0C5D11F8A0B92" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C10B6938538D916D672C5D11F8A261F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_E336D04120BAA47B2DA0C5D11F8A0B92" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C10B6938538D916D672C5D11F8A261F" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_TwoThousandAndElevenPlanMember" xlink:label="loc_cgix_TwoThousandAndElevenPlanMember_666FDA8552BE0B6B1602C5D11F8A00F5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C10B6938538D916D672C5D11F8A261F" xlink:to="loc_cgix_TwoThousandAndElevenPlanMember_666FDA8552BE0B6B1602C5D11F8A00F5" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_TwoThousandEightPlanMember" xlink:label="loc_cgix_TwoThousandEightPlanMember_ADE3CF2ACE72DCF1F222C5D11F8A449A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C10B6938538D916D672C5D11F8A261F" xlink:to="loc_cgix_TwoThousandEightPlanMember_ADE3CF2ACE72DCF1F222C5D11F8A449A" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_StrikePriceTwentyFiveOrMoreMember" xlink:label="loc_cgix_StrikePriceTwentyFiveOrMoreMember_0DDABCD19EE8222AE153C5D11F8A344E" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C10B6938538D916D672C5D11F8A261F" xlink:to="loc_cgix_StrikePriceTwentyFiveOrMoreMember_0DDABCD19EE8222AE153C5D11F8A344E" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_StrikePriceTwelvePointFiveZeroMember" xlink:label="loc_cgix_StrikePriceTwelvePointFiveZeroMember_DB2B6693A02C534025A1C5D11F8A3F58" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C10B6938538D916D672C5D11F8A261F" xlink:to="loc_cgix_StrikePriceTwelvePointFiveZeroMember_DB2B6693A02C534025A1C5D11F8A3F58" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_3C84AFF5AC6690F151F2C5D11F8A4ADC" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06F4D5A038B424BC1FF3C5D11F8AC691" xlink:to="loc_us-gaap_TitleOfIndividualAxis_3C84AFF5AC6690F151F2C5D11F8A4ADC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9BB7DFFC2DA78C479050C5D11F8A1BD7" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_3C84AFF5AC6690F151F2C5D11F8A4ADC" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9BB7DFFC2DA78C479050C5D11F8A1BD7" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NonEmployeesMember" xlink:label="loc_cgix_NonEmployeesMember_78BED2CFA52FEAF3679DC5D11F8B4788" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9BB7DFFC2DA78C479050C5D11F8A1BD7" xlink:to="loc_cgix_NonEmployeesMember_78BED2CFA52FEAF3679DC5D11F8B4788" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_EmployeesMember" xlink:label="loc_cgix_EmployeesMember_AD5B9CBF9CCEFC37E429C5D11F8BF0D1" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9BB7DFFC2DA78C479050C5D11F8A1BD7" xlink:to="loc_cgix_EmployeesMember_AD5B9CBF9CCEFC37E429C5D11F8BF0D1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06F4D5A038B424BC1FF3C5D11F8AC691" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NumberOfShareBasedEquityIncentivePlan" xlink:label="loc_cgix_NumberOfShareBasedEquityIncentivePlan_2FE6D57C1375BE1A8C1CC5D11F8B3D15" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_NumberOfShareBasedEquityIncentivePlan_2FE6D57C1375BE1A8C1CC5D11F8B3D15" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9D06FDD220ACCA95B5E2C5D11F8B880A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9D06FDD220ACCA95B5E2C5D11F8B880A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_9FCBDC2750A1C573FE05C5D11F8B096D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_9FCBDC2750A1C573FE05C5D11F8B096D" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_MaximumExercisablePeriodForOptionsGranted" xlink:label="loc_cgix_MaximumExercisablePeriodForOptionsGranted_B71D50C852C7ADB08DB9C5D11F8BD12B" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_MaximumExercisablePeriodForOptionsGranted_B71D50C852C7ADB08DB9C5D11F8BD12B" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationOutsidePlanStockOptionsIssued" xlink:label="loc_cgix_ShareBasedCompensationOutsidePlanStockOptionsIssued_73E58682F4545E1A9CF9C5D11F8B0DE7" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_ShareBasedCompensationOutsidePlanStockOptionsIssued_73E58682F4545E1A9CF9C5D11F8B0DE7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7A1C09564AD3F32EDF6DC5D11F8B03D8" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7A1C09564AD3F32EDF6DC5D11F8B03D8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_5A5684200F587A422D44C5D11F8BA462" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_5A5684200F587A422D44C5D11F8BA462" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_StockAppreciationRightsOutstanding" xlink:label="loc_cgix_StockAppreciationRightsOutstanding_A7BCD8FBBF0A0FB76E00C5D11F8BC4E5" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_StockAppreciationRightsOutstanding_A7BCD8FBBF0A0FB76E00C5D11F8BC4E5" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsStrikePrice" xlink:label="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsStrikePrice_8FCC257EDFE4FAA48E8CC5D11F8BADA5" xlink:type="locator" />
    <presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsStrikePrice_8FCC257EDFE4FAA48E8CC5D11F8BADA5" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ExchangeOptionsForNumberOfOptionsHeldWithExercisePriceEqualToInitialPublicOfferingPricePercentage" xlink:label="loc_cgix_ExchangeOptionsForNumberOfOptionsHeldWithExercisePriceEqualToInitialPublicOfferingPricePercentage_E80515B29769705E1545C5D11F8B746E" xlink:type="locator" />
    <presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_ExchangeOptionsForNumberOfOptionsHeldWithExercisePriceEqualToInitialPublicOfferingPricePercentage_E80515B29769705E1545C5D11F8B746E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:label="loc_us-gaap_EquityIssuancePerShareAmount_F9A5A72A98DEBAEB71B9C5D11F8BFCC6" xlink:type="locator" />
    <presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_EquityIssuancePerShareAmount_F9A5A72A98DEBAEB71B9C5D11F8BFCC6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_C382DDE783345D658B02C5D11F8B37FC" xlink:type="locator" />
    <presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_C382DDE783345D658B02C5D11F8B37FC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_E7F3F2C6F621F73A84A9C5D11F8B7B45" xlink:type="locator" />
    <presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_E7F3F2C6F621F73A84A9C5D11F8B7B45" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_0C74612F5A5282DE16BEC5D11F8BE187" xlink:type="locator" />
    <presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_0C74612F5A5282DE16BEC5D11F8BE187" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInStockOptionExchangeInPeriod" xlink:label="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInStockOptionExchangeInPeriod_AC7755A0FBF2EC8A1571C5D11F8B9867" xlink:type="locator" />
    <presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInStockOptionExchangeInPeriod_AC7755A0FBF2EC8A1571C5D11F8B9867" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:label="loc_cgix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_C96F4878AEB20F75F788C5D11F8B1734" xlink:type="locator" />
    <presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_C96F4878AEB20F75F788C5D11F8B1734" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesIssuedInPeriod" xlink:label="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesIssuedInPeriod_9CD25FD8AFDEF7FFC805C5D11F8C0177" xlink:type="locator" />
    <presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesIssuedInPeriod_9CD25FD8AFDEF7FFC805C5D11F8C0177" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardIssuedWeightedAveragePricePerShare" xlink:label="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardIssuedWeightedAveragePricePerShare_85BAA03A48237205745FC5D11F8C2EE7" xlink:type="locator" />
    <presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardIssuedWeightedAveragePricePerShare_85BAA03A48237205745FC5D11F8C2EE7" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_8E993D3D9AE5737F1E50C5D11F8CB9AD" xlink:type="locator" />
    <presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_8E993D3D9AE5737F1E50C5D11F8CB9AD" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_40504927B5203D0F3279C5D11F8C573F" xlink:type="locator" />
    <presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_40504927B5203D0F3279C5D11F8C573F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7501DC73FD176398A9AFC5D11F8CA91D" xlink:type="locator" />
    <presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7501DC73FD176398A9AFC5D11F8CA91D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_750222282E42AEB4A3C9C5D11F8CF20B" xlink:type="locator" />
    <presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_750222282E42AEB4A3C9C5D11F8CF20B" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_StockIssuedDuringPeriodSharesStockOptionsExercisedPricePerShare" xlink:label="loc_cgix_StockIssuedDuringPeriodSharesStockOptionsExercisedPricePerShare_CB5CFC663F09A78D1EEAC5D11F9160E8" xlink:type="locator" />
    <presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10C4FC2483648BE0FB99C5D11F8BB13B" xlink:to="loc_cgix_StockIssuedDuringPeriodSharesStockOptionsExercisedPricePerShare_CB5CFC663F09A78D1EEAC5D11F9160E8" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansEffectsOfStockBasedCompensationRelatedToStockOptionAwardsDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22FAFD4A251C8B65649AB0FD06D7C856" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable_CE0D4B94809C7A711381B0FD06D8CBD8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22FAFD4A251C8B65649AB0FD06D7C856" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable_CE0D4B94809C7A711381B0FD06D8CBD8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_DF0B700DCBF09700D9B4B0FD06D8CED8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable_CE0D4B94809C7A711381B0FD06D8CBD8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_DF0B700DCBF09700D9B4B0FD06D8CED8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_A8BF0C2C2205F1D38A7DB0FD06D8E509" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_DF0B700DCBF09700D9B4B0FD06D8CED8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_A8BF0C2C2205F1D38A7DB0FD06D8E509" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_8CA2C8D6F26F1FAD3249B0FD06D86BF0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_A8BF0C2C2205F1D38A7DB0FD06D8E509" xlink:to="loc_us-gaap_CostOfSalesMember_8CA2C8D6F26F1FAD3249B0FD06D86BF0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_B2B5045DC75E4B64FC76B0FD06D832AE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_A8BF0C2C2205F1D38A7DB0FD06D8E509" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_B2B5045DC75E4B64FC76B0FD06D832AE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_53A0244F37AEA321F0E2B0FD06D87A2A" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_A8BF0C2C2205F1D38A7DB0FD06D8E509" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_53A0244F37AEA321F0E2B0FD06D87A2A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_EAC67469E30A28A8DD6CB0FD06D80040" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_A8BF0C2C2205F1D38A7DB0FD06D8E509" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_EAC67469E30A28A8DD6CB0FD06D80040" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems_51DB0BB2D1A40F19000DB0FD06D8A674" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable_CE0D4B94809C7A711381B0FD06D8CBD8" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems_51DB0BB2D1A40F19000DB0FD06D8A674" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_D96CFB7954E69D64C76BB0FD06D8335F" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems_51DB0BB2D1A40F19000DB0FD06D8A674" xlink:to="loc_us-gaap_ShareBasedCompensation_D96CFB7954E69D64C76BB0FD06D8335F" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansSummaryOfEmployeeAndNonemployeeStockOptionActivityDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_DAC62A33D7F96F3962BCB0C4E80693F1" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A743860A792199E84DFEB0C4E80B0C65" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_DAC62A33D7F96F3962BCB0C4E80693F1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A743860A792199E84DFEB0C4E80B0C65" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_211B9128C6943BE2C712B0C4E80B39D5" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A743860A792199E84DFEB0C4E80B0C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_211B9128C6943BE2C712B0C4E80B39D5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8F2B79A2D97EDA3CCBF2B0C4E80BF47A" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A743860A792199E84DFEB0C4E80B0C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8F2B79A2D97EDA3CCBF2B0C4E80BF47A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B144CAA150D73C3EE3C5B0C4E80C8837" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A743860A792199E84DFEB0C4E80B0C65" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B144CAA150D73C3EE3C5B0C4E80C8837" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_6A0B7D781155C9EF07ADB0C4E80C7E76" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A743860A792199E84DFEB0C4E80B0C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_6A0B7D781155C9EF07ADB0C4E80C7E76" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0E539E5DE4015F173E88B0C4E80C1129" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A743860A792199E84DFEB0C4E80B0C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0E539E5DE4015F173E88B0C4E80C1129" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_66BDEB70ED445EE1F114B0C4E80C4131" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_DAC62A33D7F96F3962BCB0C4E80693F1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_66BDEB70ED445EE1F114B0C4E80C4131" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_F80C046EF1B9361A23CCB0C4E80C1712" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_DAC62A33D7F96F3962BCB0C4E80693F1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_F80C046EF1B9361A23CCB0C4E80C1712" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BB52F932B751C371BB65B0C4E80CA8AA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_F80C046EF1B9361A23CCB0C4E80C1712" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BB52F932B751C371BB65B0C4E80CA8AA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_935BEFB2CEE7DD431C75B0C4E80C5387" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_F80C046EF1B9361A23CCB0C4E80C1712" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_935BEFB2CEE7DD431C75B0C4E80C5387" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_29F076C8F3C086287118B0C4E811B30D" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_F80C046EF1B9361A23CCB0C4E80C1712" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_29F076C8F3C086287118B0C4E811B30D" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_925177442A5591903467B0C4E8125A98" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_F80C046EF1B9361A23CCB0C4E80C1712" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_925177442A5591903467B0C4E8125A98" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_D53A57B9FCC3FAF868CEB0C4E812F550" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_F80C046EF1B9361A23CCB0C4E80C1712" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_D53A57B9FCC3FAF868CEB0C4E812F550" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5F88D17147A59B099FFAB0C4E8122626" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_DAC62A33D7F96F3962BCB0C4E80693F1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5F88D17147A59B099FFAB0C4E8122626" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_A13F4786735080A9101FB0C4E8121BE1" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_DAC62A33D7F96F3962BCB0C4E80693F1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_A13F4786735080A9101FB0C4E8121BE1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2CAF617075096FFDD1BCB0C4E8128701" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_A13F4786735080A9101FB0C4E8121BE1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2CAF617075096FFDD1BCB0C4E8128701" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3FCAB48D8DAF63DA4DA2B0C4E81273A5" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_A13F4786735080A9101FB0C4E8121BE1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3FCAB48D8DAF63DA4DA2B0C4E81273A5" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_60CF18C4A2572DD4EE54B0C4E81252AB" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_DAC62A33D7F96F3962BCB0C4E80693F1" xlink:to="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_60CF18C4A2572DD4EE54B0C4E81252AB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_39506AF65C896A8B9F89B0C4E8127129" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_60CF18C4A2572DD4EE54B0C4E81252AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_39506AF65C896A8B9F89B0C4E8127129" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1A69D90B440DB57C72BAB0C4E812DABC" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_60CF18C4A2572DD4EE54B0C4E81252AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1A69D90B440DB57C72BAB0C4E812DABC" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_DEAE8B5B51F29449A638B0C4E8128B3C" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_60CF18C4A2572DD4EE54B0C4E81252AB" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_DEAE8B5B51F29449A638B0C4E8128B3C" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansSummaryOfOutstandingAndVestedStockOptionsGrantedDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_EDA1229161330DCA8FFBC5D11F611818" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_D4232D37A91461D2EB77C5D11F61F1DF" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_EDA1229161330DCA8FFBC5D11F611818" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_D4232D37A91461D2EB77C5D11F61F1DF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0233DA74B1B377AE8109C5D11F614F56" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_D4232D37A91461D2EB77C5D11F61F1DF" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0233DA74B1B377AE8109C5D11F614F56" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0233DA74B1B377AE8109C5D11F614F56" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ExercisePriceFourMember" xlink:label="loc_cgix_ExercisePriceFourMember_89F3718EC90DD572271BC5D11F610880" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:to="loc_cgix_ExercisePriceFourMember_89F3718EC90DD572271BC5D11F610880" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ExercisePriceFourPointEightZeroMember" xlink:label="loc_cgix_ExercisePriceFourPointEightZeroMember_3893AF1F28B2748D9917C5D11F61F7AA" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:to="loc_cgix_ExercisePriceFourPointEightZeroMember_3893AF1F28B2748D9917C5D11F61F7AA" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ExercisePriceTenMember" xlink:label="loc_cgix_ExercisePriceTenMember_045B2273C5D12B4EF214C5D11F611428" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:to="loc_cgix_ExercisePriceTenMember_045B2273C5D12B4EF214C5D11F611428" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ExercisePriceRangeElevenPointSeventytoElevenPointSeventyFiveMember" xlink:label="loc_cgix_ExercisePriceRangeElevenPointSeventytoElevenPointSeventyFiveMember_2386D6306F68CA98CAF6C697E40546A4" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:to="loc_cgix_ExercisePriceRangeElevenPointSeventytoElevenPointSeventyFiveMember_2386D6306F68CA98CAF6C697E40546A4" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ExercisePriceRangeTwelvePointFiveZerotoFourteenPointEighteenMember" xlink:label="loc_cgix_ExercisePriceRangeTwelvePointFiveZerotoFourteenPointEighteenMember_8036DC58AA3F695058D2C69906277835" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:to="loc_cgix_ExercisePriceRangeTwelvePointFiveZerotoFourteenPointEighteenMember_8036DC58AA3F695058D2C69906277835" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ExercisePriceFifteenPointThreeNineMember" xlink:label="loc_cgix_ExercisePriceFifteenPointThreeNineMember_D059CC389F917403022BC5D11F6256F7" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:to="loc_cgix_ExercisePriceFifteenPointThreeNineMember_D059CC389F917403022BC5D11F6256F7" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ExercisePriceFifteenPointEightyNineMember" xlink:label="loc_cgix_ExercisePriceFifteenPointEightyNineMember_506CF1BA69665CDB49EDC5D11F6234DD" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:to="loc_cgix_ExercisePriceFifteenPointEightyNineMember_506CF1BA69665CDB49EDC5D11F6234DD" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ExercisePriceSeventeenPointThreeEightMember" xlink:label="loc_cgix_ExercisePriceSeventeenPointThreeEightMember_0C99AE0BC8ABC08770B9C668A2105908" xlink:type="locator" />
    <presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_F8E5BCC95F389DD0FD2FC5D11F614B79" xlink:to="loc_cgix_ExercisePriceSeventeenPointThreeEightMember_0C99AE0BC8ABC08770B9C668A2105908" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0741346669B619CB619FC5D11F622504" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_D4232D37A91461D2EB77C5D11F61F1DF" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0741346669B619CB619FC5D11F622504" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_BE563D984C776D3BD998C69BD2C544B0" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0741346669B619CB619FC5D11F622504" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_BE563D984C776D3BD998C69BD2C544B0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_D461633E6E3C75EF7051C5D11F624CF4" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0741346669B619CB619FC5D11F622504" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_D461633E6E3C75EF7051C5D11F624CF4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_79D0E175A6000B1B134FC5D11F6235E3" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0741346669B619CB619FC5D11F622504" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_79D0E175A6000B1B134FC5D11F6235E3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_A9266FBE11D0A6EA7D99C5D11F6216C5" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0741346669B619CB619FC5D11F622504" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_A9266FBE11D0A6EA7D99C5D11F6216C5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_571F949D428DBDBCF55FC5D11F6283F2" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0741346669B619CB619FC5D11F622504" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_571F949D428DBDBCF55FC5D11F6283F2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_8F8BC11512D2CBC054C7C5D11F626E11" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0741346669B619CB619FC5D11F622504" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_8F8BC11512D2CBC054C7C5D11F626E11" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2677AE5261B1157D6463C5D11F62D24E" xlink:type="locator" />
    <presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0741346669B619CB619FC5D11F622504" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2677AE5261B1157D6463C5D11F62D24E" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A79FB7E56138895F0984CE191C0B36D3" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7F434733F0AA784E2588CE191C0CF2C4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A79FB7E56138895F0984CE191C0B36D3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7F434733F0AA784E2588CE191C0CF2C4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_78C69930A15BFE67F2A9CE191C0CF29E" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A79FB7E56138895F0984CE191C0B36D3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_78C69930A15BFE67F2A9CE191C0CF29E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_32F7C10F5943712BB7BCCE191C0C391F" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A79FB7E56138895F0984CE191C0B36D3" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_32F7C10F5943712BB7BCCE191C0C391F" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_80F5ED2F45EC2264F1B2CE191C0CE476" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A79FB7E56138895F0984CE191C0B36D3" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_80F5ED2F45EC2264F1B2CE191C0CE476" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansWeightedAverageAssumptionsUsedToEstimateFairValueOfOptionsGrantedDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8BD3776B42ED8A55C4E2B0EED1E134B6" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D2B81D443449C05ACA17B0EED1E7C871" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8BD3776B42ED8A55C4E2B0EED1E134B6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D2B81D443449C05ACA17B0EED1E7C871" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_4888B53C13C70B0F3987B0EED1E77E07" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D2B81D443449C05ACA17B0EED1E7C871" xlink:to="loc_us-gaap_TitleOfIndividualAxis_4888B53C13C70B0F3987B0EED1E77E07" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_BA9A4515A9CE0834A86EB0EED1E74450" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_4888B53C13C70B0F3987B0EED1E77E07" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_BA9A4515A9CE0834A86EB0EED1E74450" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_NonEmployeesMember" xlink:label="loc_cgix_NonEmployeesMember_B619DC233413A6099DE8B0EED1E8BF71" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_BA9A4515A9CE0834A86EB0EED1E74450" xlink:to="loc_cgix_NonEmployeesMember_B619DC233413A6099DE8B0EED1E8BF71" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D247FB0DB21B20D6C52CB0EED1E86966" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D2B81D443449C05ACA17B0EED1E7C871" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D247FB0DB21B20D6C52CB0EED1E86966" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_D2138ED63FD186FB2F6AB0EED1E8E8C6" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D247FB0DB21B20D6C52CB0EED1E86966" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_D2138ED63FD186FB2F6AB0EED1E8E8C6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4974B816B216E7FD85D2B0EED1E8AA96" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D247FB0DB21B20D6C52CB0EED1E86966" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4974B816B216E7FD85D2B0EED1E8AA96" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9306C8FC6AA27BF4AD8EB0EED1E8EB09" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D247FB0DB21B20D6C52CB0EED1E86966" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9306C8FC6AA27BF4AD8EB0EED1E8EB09" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2C2DCA4B43DEC3EF0919B0EED1ED243A" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D247FB0DB21B20D6C52CB0EED1E86966" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2C2DCA4B43DEC3EF0919B0EED1ED243A" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/Warrants" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_AAE8F10E119327839D4FC7069AF4F606" xlink:type="locator" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WarrantsDisclosureTextBlock" xlink:label="loc_cgix_WarrantsDisclosureTextBlock_E53299DF99F44A9D7A8CC5C9FF10B435" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_AAE8F10E119327839D4FC7069AF4F606" xlink:to="loc_cgix_WarrantsDisclosureTextBlock_E53299DF99F44A9D7A8CC5C9FF10B435" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/WarrantsAdditionalInformationDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_53DF2DDA4525595E4E4AC5C9F6445A61" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_20DEA98CED63E69E4B6EC5DD069BF124" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_53DF2DDA4525595E4E4AC5C9F6445A61" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_20DEA98CED63E69E4B6EC5DD069BF124" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6D4807B194263E21F9D0C5D95376FD7C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_20DEA98CED63E69E4B6EC5DD069BF124" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6D4807B194263E21F9D0C5D95376FD7C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7B9FBDDBDA61EE83A6C5C5D9537720A2" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6D4807B194263E21F9D0C5D95376FD7C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7B9FBDDBDA61EE83A6C5C5D9537720A2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_16C5A66FF26FCA83DBAFC5D9B6F4EC3C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7B9FBDDBDA61EE83A6C5C5D9537720A2" xlink:to="loc_us-gaap_SubsequentEventMember_16C5A66FF26FCA83DBAFC5D9B6F4EC3C" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_5EEC5720D42FAAE1783FC5DD069DA08B" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_20DEA98CED63E69E4B6EC5DD069BF124" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_5EEC5720D42FAAE1783FC5DD069DA08B" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_366C26B620E82E9E4409C5C9F64415D9" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5EEC5720D42FAAE1783FC5DD069DA08B" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_366C26B620E82E9E4409C5C9F64415D9" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_CommonStockSharesIssuedOnExerciseOfWarrant" xlink:label="loc_cgix_CommonStockSharesIssuedOnExerciseOfWarrant_552AEEB66FA378C68A2CC5C9F64466E4" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5EEC5720D42FAAE1783FC5DD069DA08B" xlink:to="loc_cgix_CommonStockSharesIssuedOnExerciseOfWarrant_552AEEB66FA378C68A2CC5C9F64466E4" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_CommonStockPurchasePricePerWarrant" xlink:label="loc_cgix_CommonStockPurchasePricePerWarrant_B3408A45D3F2CA98CF42C5C9F644178E" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5EEC5720D42FAAE1783FC5DD069DA08B" xlink:to="loc_cgix_CommonStockPurchasePricePerWarrant_B3408A45D3F2CA98CF42C5C9F644178E" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ClassOfWarrantOrRightSurrendered" xlink:label="loc_cgix_ClassOfWarrantOrRightSurrendered_FA097134CEFEF29977F5C5C9F6446A9E" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5EEC5720D42FAAE1783FC5DD069DA08B" xlink:to="loc_cgix_ClassOfWarrantOrRightSurrendered_FA097134CEFEF29977F5C5C9F6446A9E" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ClassOfWarrantOrRightIssued" xlink:label="loc_cgix_ClassOfWarrantOrRightIssued_2331A41EB334256DE7E1C5C9F6440A32" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5EEC5720D42FAAE1783FC5DD069DA08B" xlink:to="loc_cgix_ClassOfWarrantOrRightIssued_2331A41EB334256DE7E1C5C9F6440A32" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/WarrantsSummaryOfWarrantActivityDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_57752A3452E023AEE50FC5C9F64F0D69" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_30FFCC5DBA090E2B2558C5C9F64F59AA" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_57752A3452E023AEE50FC5C9F64F0D69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_30FFCC5DBA090E2B2558C5C9F64F59AA" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_6544CB921A1AE2C153E4C5C9F650C34A" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_30FFCC5DBA090E2B2558C5C9F64F59AA" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_6544CB921A1AE2C153E4C5C9F650C34A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_034F724FDB3BBB4AF83BC5C9F6505444" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_6544CB921A1AE2C153E4C5C9F650C34A" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_034F724FDB3BBB4AF83BC5C9F6505444" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FinancingOneMember" xlink:label="loc_cgix_FinancingOneMember_3B291C3129F294993CE2C5C9F65029C4" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_034F724FDB3BBB4AF83BC5C9F6505444" xlink:to="loc_cgix_FinancingOneMember_3B291C3129F294993CE2C5C9F65029C4" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FinancingTwoMember" xlink:label="loc_cgix_FinancingTwoMember_EB521C441DEF4E5C720DC5C9F6506AE2" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_034F724FDB3BBB4AF83BC5C9F6505444" xlink:to="loc_cgix_FinancingTwoMember_EB521C441DEF4E5C720DC5C9F6506AE2" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ConsultingOneMember" xlink:label="loc_cgix_ConsultingOneMember_6EE448C26A6153013C59C5C9F6509381" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_034F724FDB3BBB4AF83BC5C9F6505444" xlink:to="loc_cgix_ConsultingOneMember_6EE448C26A6153013C59C5C9F6509381" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_FinancingThreeMember" xlink:label="loc_cgix_FinancingThreeMember_D55A5DB473916CE806D4C5C9F650F3A2" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_034F724FDB3BBB4AF83BC5C9F6505444" xlink:to="loc_cgix_FinancingThreeMember_D55A5DB473916CE806D4C5C9F650F3A2" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ConsultingTwoMember" xlink:label="loc_cgix_ConsultingTwoMember_16056529DDC97677CF98C5C9F650028A" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_034F724FDB3BBB4AF83BC5C9F6505444" xlink:to="loc_cgix_ConsultingTwoMember_16056529DDC97677CF98C5C9F650028A" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_AFEA2D736DB6868CC42EC5C9F6500061" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_30FFCC5DBA090E2B2558C5C9F64F59AA" xlink:to="loc_us-gaap_StatementClassOfStockAxis_AFEA2D736DB6868CC42EC5C9F6500061" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_D8413537A127D429DF85C5C9F650B321" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_AFEA2D736DB6868CC42EC5C9F6500061" xlink:to="loc_us-gaap_ClassOfStockDomain_D8413537A127D429DF85C5C9F650B321" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_8A6E870818611852DB5FC5C9F650ACC8" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_D8413537A127D429DF85C5C9F650B321" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_8A6E870818611852DB5FC5C9F650ACC8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_4779BED1628D82F70F47C5C9F6505BF4" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_30FFCC5DBA090E2B2558C5C9F64F59AA" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_4779BED1628D82F70F47C5C9F6505BF4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_8D2546FDD55CEFB74E59C5C9F6500E48" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_4779BED1628D82F70F47C5C9F6505BF4" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_8D2546FDD55CEFB74E59C5C9F6500E48" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DebtRelatedGuaranteesOneMember" xlink:label="loc_cgix_DebtRelatedGuaranteesOneMember_FD99EAC21959596FAFA6C5C9F6504B5E" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_8D2546FDD55CEFB74E59C5C9F6500E48" xlink:to="loc_cgix_DebtRelatedGuaranteesOneMember_FD99EAC21959596FAFA6C5C9F6504B5E" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DebtRelatedGuaranteesTwoMember" xlink:label="loc_cgix_DebtRelatedGuaranteesTwoMember_91286DC4029E9C0C29C0C5C9F65028FE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_8D2546FDD55CEFB74E59C5C9F6500E48" xlink:to="loc_cgix_DebtRelatedGuaranteesTwoMember_91286DC4029E9C0C29C0C5C9F65028FE" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DebtRelatedGuaranteesThreeMember" xlink:label="loc_cgix_DebtRelatedGuaranteesThreeMember_A4F090CA78A9096B4E8FC5C9F650CAAA" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_8D2546FDD55CEFB74E59C5C9F6500E48" xlink:to="loc_cgix_DebtRelatedGuaranteesThreeMember_A4F090CA78A9096B4E8FC5C9F650CAAA" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_DebtRelatedGuaranteesFourMember" xlink:label="loc_cgix_DebtRelatedGuaranteesFourMember_3902F6E633DF6F3ECEBDC5C9F6502270" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_8D2546FDD55CEFB74E59C5C9F6500E48" xlink:to="loc_cgix_DebtRelatedGuaranteesFourMember_3902F6E633DF6F3ECEBDC5C9F6502270" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_C64F44561157B68563E7C5C9F651F517" xlink:type="locator" />
    <presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_30FFCC5DBA090E2B2558C5C9F64F59AA" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_C64F44561157B68563E7C5C9F651F517" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_A272426FB409A72FD1CEC5C9F6516404" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_C64F44561157B68563E7C5C9F651F517" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_A272426FB409A72FD1CEC5C9F6516404" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WarrantIssuedWithMember" xlink:label="loc_cgix_WarrantIssuedWithMember_027A13D36D812C13BC62C5C9F651F4BE" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_A272426FB409A72FD1CEC5C9F6516404" xlink:to="loc_cgix_WarrantIssuedWithMember_027A13D36D812C13BC62C5C9F651F4BE" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WarrantIssuedForMember" xlink:label="loc_cgix_WarrantIssuedForMember_F596BAF595D9B37804F4C5C9F6514F94" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_A272426FB409A72FD1CEC5C9F6516404" xlink:to="loc_cgix_WarrantIssuedForMember_F596BAF595D9B37804F4C5C9F6514F94" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareholdersEquityClassAxis" xlink:label="loc_us-gaap_ShareholdersEquityClassAxis_27D5DDDB76E1169DF88DC5C9F65117DF" xlink:type="locator" />
    <presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_30FFCC5DBA090E2B2558C5C9F64F59AA" xlink:to="loc_us-gaap_ShareholdersEquityClassAxis_27D5DDDB76E1169DF88DC5C9F65117DF" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByShareholdersEquityClassDomain" xlink:label="loc_us-gaap_FairValueByShareholdersEquityClassDomain_106AA89F0B6838588BB8C5C9F651B040" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareholdersEquityClassAxis_27D5DDDB76E1169DF88DC5C9F65117DF" xlink:to="loc_us-gaap_FairValueByShareholdersEquityClassDomain_106AA89F0B6838588BB8C5C9F651B040" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WarrantsOtherWarrantsMember" xlink:label="loc_cgix_WarrantsOtherWarrantsMember_926641BEF6E6226EF479C5C9F651B58D" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByShareholdersEquityClassDomain_106AA89F0B6838588BB8C5C9F651B040" xlink:to="loc_cgix_WarrantsOtherWarrantsMember_926641BEF6E6226EF479C5C9F651B58D" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_WarrantDerivativeMember" xlink:label="loc_cgix_WarrantDerivativeMember_0AE6B275F1E742D2A17AC5C9F65169BE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByShareholdersEquityClassDomain_106AA89F0B6838588BB8C5C9F651B040" xlink:to="loc_cgix_WarrantDerivativeMember_0AE6B275F1E742D2A17AC5C9F65169BE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_AA7FFB1ED9E4C78CB42EC5C9F651712E" xlink:type="locator" />
    <presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_30FFCC5DBA090E2B2558C5C9F64F59AA" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_AA7FFB1ED9E4C78CB42EC5C9F651712E" xlink:type="arc" />
    <loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_5790F9997D1A737D2CC1C5C9F651CA65" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_AA7FFB1ED9E4C78CB42EC5C9F651712E" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_5790F9997D1A737D2CC1C5C9F651CA65" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ClassofWarrantsOutstandingRollForward" xlink:label="loc_cgix_ClassofWarrantsOutstandingRollForward_454195D007001615F2DFC5CD68FCB0CE" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_AA7FFB1ED9E4C78CB42EC5C9F651712E" xlink:to="loc_cgix_ClassofWarrantsOutstandingRollForward_454195D007001615F2DFC5CD68FCB0CE" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_CF2F17E21E797E135391C5C9F651D5E3" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ClassofWarrantsOutstandingRollForward_454195D007001615F2DFC5CD68FCB0CE" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_CF2F17E21E797E135391C5C9F651D5E3" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ClassOfWarrantOrRightExercised" xlink:label="loc_cgix_ClassOfWarrantOrRightExercised_72ACAF6A3CC958077213C5C9F651D4AB" xlink:type="locator" />
    <presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ClassofWarrantsOutstandingRollForward_454195D007001615F2DFC5CD68FCB0CE" xlink:to="loc_cgix_ClassOfWarrantOrRightExercised_72ACAF6A3CC958077213C5C9F651D4AB" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_470926EE46688BB1EE41C5C9F65192B0" xlink:type="locator" />
    <presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cgix_ClassofWarrantsOutstandingRollForward_454195D007001615F2DFC5CD68FCB0CE" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_470926EE46688BB1EE41C5C9F65192B0" xlink:type="arc" />
  </presentationLink>
  <presentationLink xlink:role="http://www.cancergenetics.com/role/WarrantsTables" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_8E7A31B19C98CCECD2CBC7066B326474" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_A9D8811A6576DD8D01B2C5C9F631D24C" xlink:type="locator" />
    <presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8E7A31B19C98CCECD2CBC7066B326474" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_A9D8811A6576DD8D01B2C5C9F631D24C" xlink:type="arc" />
  </presentationLink>
</linkbase>


